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The single layer of epithelial cells that line the intestinal tract provides both a 
physiologic and immunologic barrier for microbes and foreign antigens. Intestinal 
epithelial cells are differentiated into different functional subtypes and have regulatory 
roles in maintaining the homeostasis of the gut as well as initiating inflammatory 
responses during pathogenic infections.  Toxoplasma gondii is a widespread zoonotic 
protozoan parasite that infects warm-blooded animals.  Infection usually occurs 
through ingestion of T. gondii contaminated food or water.   Therefore, natural route 
of infection has revealed the importance of epithelial cell response in influencing the 
outcome of the local and systemic immune response. 
 
In this thesis, I examined the innate immune response of intestinal epithelial cell 
during T. gondii infection.  The immediate response upon intestinal epithelial and 
parasite contact revealed that T. gondii infected epithelial cells elicited MAPK 
phosphorylation, NF-!B activation, and secretion of IL-8 as well as several other 
inflammatory cytokines and chemokines in epithelial cells.   I found that activation of 
MAPK and production of IL-8 was dependent on the MyD88 signaling pathway, and 
TLR2 was sufficient for parasite induced signaling in HEK 293 transfected cells.   In 
addition, TLR2 signaling plays an important role in modulating of the local intestinal 
environment by inducing migration of dendritic cells into the follicle-associated 
 epithelium of Peyer’s patches.  Using the susceptible C57BL/6 mice as a model, 
morphological changes of different intestinal epithelial cell subtypes in response to 
peroral T. gondii infection were further characterized.  Oral infection with T. gondii 
ME49 cysts induced intestinal pathology and morphological changes of different 
epithelial cell subtypes.  Mice deficient in TLR2 were more resistant to intestinal 
pathology and associated morphological changes.  Parasite–derived TLR2 stimulatory 
molecules were found to be present in the supernatant collected from T. gondii 
infected cells.  Therefore, potential biological significance of the activity in 
supernatants from T. gondii infected cells was also investigated.  I found that the 
supernatants from T. gondii infected cells enhanced luminal antigen uptake and 
induced TLR2-dependent migration of dendritic cells to the follicle associated 
epithelium of Peyer’s patches.  Furthermore, analysis of the supernatant revealed 
several T. gondii proteins, and the GPI-anchored surface antigen-1 contributes to 
TLR2 stimulatory activity. 
 
In summary, this dissertation explores the innate immune response of the intestinal 
epithelium during T. gondii infection.  The signaling pathways of intestinal epithelial 
cells elicited by the parasite as well as the modulation of the local intestinal 
environment can help us better understand the immunopathogenesis of T. gondii 
infection. 
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CHAPTER I 
INTRODUCTION 
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1.   Life cycle of Toxoplasma gondii 
Toxoplasma gondii is an obligate intracellular protozoan parasite that can infect warm-
blooded animals, and is arguably one of the most successful parasitic organisms 
worldwide.   It was originally discovered in 1908 by Nicolle and Manceaux, who 
found the parasite in tissues of the rodent Ctenodactylus gundii.  They named this new 
organism (toxon meaning arc or bow in Greek, and plasma meaning life) based on the 
crescent-shaped morphology, and the host species in which it was originally 
discovered (1, 2).  Toxoplasma belongs to the Phylum Apicomplexa, Class 
Sporozoasida, Subclass Coccidiasina, Order Eimeriorina, and Family 
Toxoplasmatidae.  There is only one species of Toxoplasma gondii (3). 
 
There are three different infectious stages for T. gondii: sporozoite-containing oocysts, 
tachyzoites, and bradyzoite-containing tissue cysts.  Sporozoites are disseminated in 
the environment within oocysts, tachyzoites are rapidly replicating forms that facilitate 
expansion during acute infection, and bradyzoites are in a quiescent form that is 
maintained during chronic infection. Tachyzoites and bradyzoites are associated with 
the intermediate host, whereas sporozoites are only associated with its definitive host.  
All three stages are haploid; tachyzoites and bradyzoites divide asexually, and 
sporozoites are derived from meiosis (4, 5).     
 
T. gondii has a complex life cycle consisting of a sexual cycle in felidae, the definitive 
hosts, and an asexual cycle in its intermediate hosts.   The life cycle of T. gondii 
begins with cats that have ingested the parasite at any of the 3 infectious stages.    
After ingestion of tissue cysts or oocysts by cats, the cyst wall is digested by 
proteolytic enzymes in the small intestine.   When the parasites are released they 
penetrate into epithelial cells and multiply as tachyzoites in the small intestine.  Five 
  3 
morphologically distinct asexual types are formed in the intestinal epithelial cells and 
eventually lead to a sexual cycle resulting in the production of oocysts (6). The 
prepatent period is from 3 -10 days following cyst ingestion, approximately 18 days 
after ingesting oocysts, and approximately 13 days after ingesting tachyzoites (6).  
Nearly all cats shed oocysts after ingesting tissue cysts, but only a few shed oocysts 
after ingesting tachyzoites or oocysts.  Unsporulated oocysts are non-infectious, but 
they can sporulate quickly within 5 days and become infectious (7-9).   Intermediate 
hosts and humans are infected with T. gondii by ingesting animal tissue cysts or food 
and water contaminated with oocysts.   After ingestion, brazyzoites or sporozoites 
transform into rapidly replicating tachyzoites and disseminate out of the intestine and 
spread throughout the body.  Vertical transmission can also occur through 
transplacental infection of tachyzoites from mother to fetus (Fig 1.1). 
 
2.   Clinical Aspects of T. gondii  
Epidemiological studies have suggested as much as 1/3 of the human population may 
harbor T. gondii infection; however the seroprevalence for T. gondii varies from 
population group and geographic region (10).  Most infections in immunocompetent 
individuals are asymptomatic, yet the individual remains infected throughout their 
lifetime.  Toxoplasmic encephalitis is a very serious disease following reactivation of 
the parasite due to various mechanisms of immunosuppression.  Encephalitic disease 
is the most important manifestation of toxoplasmosis in immunocompromised 
individuals such as HIV-infected patients, and organ/bone marrow transplant patients 
treated with immunosuppressive drugs (11).   Only a minority of healthy individuals 
infected with T. gondii develop symptoms, such as fever, malaise, and swollen lymph 
nodes (10). In congenital transmission, the fetus becomes infected if the mother 
acquires the parasite for the first time during pregnancy. T. gondii tachyzoites can 
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Figure 1.1.  Life cycle of Toxoplasma gondii.   T. gondii oocysts are only produced in 
the definitive host (cats).  Intermediate hosts become infected after ingesting oocyst 
contaminated feed, soil, or water.   Oocysts sporulate to an infective form rapidly in 
the environment. Sporulated oocysts transform into tachyzoites after ingestion and 
spread systemically to the brain and muscle tissue to become tissue cyst containing 
bradyzoites.   Cats can be infected by ingesting oocysts or from intermediate hosts 
harboring tissue cysts.  Humans can also be infected through consuming food or water 
contaminated with oocysts, or eating undercooked meat from infected animals.  The 
fetus can be infected through transplacental infection.   
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enter the fetus through placental infection, and lead to a variety of manifestations in 
the fetus depending on the stage of the gestation such as damage to the central nervous 
cystem, and chorioretinitis.   The risk of congenital infection is 10–15% when 
maternal infection is in the first trimester, and up to 60–90% during the third trimester 
(12-15).   While clinical toxoplasmosis is not a major problem in livestock, T. gondii 
can cause severe disease in ovine. Abortion and neonatal mortality in dairy goats and 
sheep worldwide is a source of significant economic loss (16-18).  
 
The standard drug combinations for treating toxoplasmosis are pyrimethamine, 
sulfadiazine, and folinic acid treatment for 4-6 weeks (10).   For maternal infection, 
spiramycin is used during the first and second trimester, pyrimethamine, sulfadiazine, 
and spiramycin combinations are used for the late second and third trimester when 
fetus infection is confirmed with PCR analysis of the amniotic fluid.  In cases of 
suspected infection but test negative for PCR analysis, pregnant women are treated 
with spiramycin prophylaxis until the 17th week of pregnancy (10).    
 
Diagnosis of T. gondii infection can be achieved indirectly with serological methods 
and directly by PCR.   Indirect serological methods by detection IgG antibodies to T. 
gondii are widely used in immunocompetent individuals and pregnant women.  IgG 
antibodies to T. gondii can be detected after 2 weeks of infection and persist in the 
host throughout their lifetime.  Common methods for detecting serum IgG antibodies 
include: the Sabin-Feldman dye test, immunofluorescent antibody test, ELISA based 
assays, IgG avidity test, and agglutination and differential agglutination test (19-23).   
For direct detection, the T. gondii repetitive gene B1 is often used at targets for PCR 
amplification of body fluid and tissue samples (24-26). 
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Currently there is no vaccine to prevent T. gondii infection in animals and humans.   
The commercial vaccine “Toxovax®” is used for limiting abortion in sheep, but 
protection is of short duration and does not completely eradicate the parasite (27, 28).   
Studies on human vaccine development have focussed on antigens that stimulate Th1 
immune response.  Considering that T. gondii is a pathogen that infects the host 
through the oral route, it is important to develop a vaccine that stimulates mucosal 
immunity effectively.   Recent studies on designing T. gondii vaccines have used 
defined subcellular components of the parasite, such as native antigens obtained from 
tachyzoites (surface antigens, rhoptry antigens, dense granule antigens, and 
microneme antigens) (29, 30), recombinant antigens (31), and the construction of 
auxotrophic T. gondii mutants (32).   Interestingly, GPIs from T. gondii stimulate 
inflammatory responses and are potential targets for vaccine development (33).   
 
3.  Cellular biology and virulence of T. gondii 
T. gondii is an intracellular parasite that can actively infect any nucleated cell.  The 
three infectious stages of T. gondii are similar in morphology, but differ in some 
organelles and inclusion bodies.  Both oocysts and tissue cysts differentiate into 
tachyzoites once they invade the host cell after ingestion by the host.  Tachyzoites are 
the most well characterized stage, and can be clonally propagated both in vitro and in 
vivo.   They are crescent shaped (2 ! 6 µm) with a pointed anterior end and a rounded 
posterior end.  The structure of T. gondii is shown in Fig 1.2.  Entry of the tachyzoites 
into the host is an active process that involves gliding motility to approach a host cell, 
tight binding of host receptors during attachment, and active penetration into the host 
cell (34, 35).  During invasion, specialized secretory organelles such as micronemes, 
rhoptries and dense granules are discharged from the apical end and assist in invasion 
and remodeling of the host cell.  Micronemes secrete MIC proteins that are adhesion  
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Figure 1.2.  The structure of T. gondii.  T. gondii has the basic features of an 
eukaryotic cell including a nucleus, endoplasmic reticulum, and Golgi.  The conoid 
located at the apical end is composed of microtubule elements.  The three secretory 
organelles, micronemes, rhoptries, and dense granules secrete various MIC, ROP, and 
GRA proteins, respectively, which play an important role during the invasion process.  
The mitochondria and apicoplast contains extra-chromosomal genomes in addition to 
the nucleus.   
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proteins important for host cell entry (36-39).   Rhoptries produce ROP and RON 
proteins that form the moving junctions during invasion and contribute to the 
formation of the parasitophorous vacuole once inside the cell (40-45).   Dense 
granules secrete GRA proteins that facilitate the formation of specialized tubules for 
nutrient acquisition by the parasite (46-49).   
 
T. gondii isolates from humans and animals in the Europe and North America  region 
belong to three clonal lineages (50, 51).  In mice, the type I strains are highly virulent, 
whereas type II and type III are considered avirulent (52). In Europe and North 
America, type II strains are most commonly associated with human toxoplasmosis  
(53, 54), and type II (pigs, sheep) or type III (chickens) strains are mostly isolated 
from livestock.  The three clonal lineages differ in growth rate, migration and 
virulence, which lead to strain-specific differences and interaction with the host. In 
vitro infections with different clonal lineages results in different host cell gene 
regulation and activation of signaling pathways (52, 55-58).  Modulation signaling 
pathways of the host cells alters the proinflammatory cytokine production and also 
results in a difference of the disease outcome in mice (59, 60). 
 
4.   Immunology of T. gondii infection 
Several studies have shown that T. gondii infection is predominantly controlled by T-
cell-mediated immunity (61).  Nude mice that lack a thymus, and therefore do not 
produce functional T cells, are extremely susceptible to T. gondii infection (62, 63).   
Furthermore, depletion of CD4+ and CD8+ T cells in chronically infected mice results 
in toxoplasmic encephalitis (64).  Adoptive transfer of T. gondii-specific T cells from 
chronically infected mice to naïve mice provides protection against T. gondii 
challenge demonstrating that specific T cells alone are protective (65, 66).  Infections 
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with T. gondii also activate humoral immunity.  In B cell-deficient mice, although 
normal levels of IFN-!, TNF-!, and inducible nitric oxide synthase (iNOS) were 
produced during the acute phase of infection, mice succumbed during chronic 
infection due to uncontrolled parasite replication as well as brain and lung pathology 
(67).  Oral infection with T. gondii also induces specific secretory immunoglobulin A 
(IgA) in the gut, sera, and milk (68).  
 
Primary infection with T. gondii elicits a strong Th1-polarized response characterized 
by the production of high amounts of IFN-!, IL-12, and other proinflammatory 
cytokines such as TNF"!. IFN-! is essential for controlling the acute and chronic 
stage of infection since depletion of IFN-! by monoclonal antibodies or gene knockout 
studies increased susceptibility to infection (69, 70).    During the acute stage of 
infection, T cells and natural killer (NK) cells are the major source for IFN-!, and 
during the chronic stage production is mostly from !# T cells (64, 71-73).  Both 
CD4+ and CD8+ T cells are required for preventing the reactivation of parasite (64).   
However, while CD4+ T helper cells are important for driving CD8+ T cell 
differentiation, they may also play an immunopathogenic role that causes tissue 
damage (74).    
 
Innate immune cells such as macrophages, dendritic cells, and neutrophils are the 
main producers of IL-12, which is necessary for the induction of IFN-! to control T. 
gondii infection (Fig 1.3) (72, 75-80).  Mice deficient in IL-12 are extremely 
susceptible to acute infection due to impaired production of IFN-g (81).  In addition to 
IL-12 production, both macrophages and dendritic cells can present antigens to T 
cells.  Macrophages activated by IFN-$ become effector cells with increased  
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Figure 1.3.  Immune response during T. gondii infection. Dendritic cells, 
neutrophils, and macrophages produce IL-12 during T. gondii infection.   IL-12 is 
critical for activating natural killer (NK) cells, CD4+ Th1 cells, and CD8+ T cells to 
produce IFN- !. IFN- ! is can promote the production of nitric oxide, IFN- ! -inducible 
guanosine triphosphate binding proteins (IGTPs), and LRG-47 that contain 
microbicidal activity.  Macrophages primed with IFN- ! can also become effector cells 
against T. gondii. 
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antimicrobial activity, increased phagocytic activity, and induced production of nitric 
oxide (82). IFN- ! priming of dendritic cells can also limit intracellular growth of T. 
gondii (83).  Neutrophils are also early-response cells and produce IL-12 and TNF-" 
during T. gondii infection (77, 79).  They respond to chemoattractants such as IL-8 
(MIP-2 and KC in mice), migrate rapidly to the site of infection, phagocytose 
parasites, and release microbicidal molecules such as reactive oxygen intermediates 
(ROI) and degradative enzymes (77, 84, 85).  Studies have shown the essential role for 
neutrophils during the acute phase of T. gondii infection.  Mice depleted of neutrophils 
are highly susceptible to T. gondii infection due to high parasite burden, a phenotype 
similar to IFN- !, IL-12 and MyD88 deficient mice (84, 86, 87).        
 
In order to prevent excessive immune response in the host, the innate immune cells 
can also produce anti-inflammatory cytokines such as IL-10, IL-4, and TGF-#.  Mice 
deficient in IL-10 have increased immunopathology following infection with T. 
gondii, which correlates with increased IL-12, IFN-! and TNF-", despite a similar 
parasite burden (88). IL-10 inhibits cell-mediated immunity by downregulating the 
expression of costimulatory molecules required for T-cell activation.  In addition to 
IL-10, both IL-4 and TGB-# regulate inflammation and limit cell based immunity.  
TGF- # synergizes with IL-10 to inhibit macrophage effector function, and IL-12-
induced production of IFN-! by NK cells (89-91).    
 
The mucosa is a major entry site for most pathogens.  Intestinal epithelial cells are the 
first cell type that encounters infectious agents including T. gondii.  Therefore the 
intestinal epithelium is a critical site for initiation of host immunity, as well as for 
orchestrating the response of immune cells in the lamina propria.   In this thesis, I will 
focus on the mucosal epithelial immune response during T. gondii infection. 
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5.  Mucosal epithelial cells and immune regulation in the gut 
The gut consists of the epithelial layer, the gut-associated lymphoid tissues (GALT), 
and the commensal flora.  The single layer of epithelial cells that line the intestinal 
lumen is important for digestion, nutrient absorption, as well as formation of a 
physical barrier.  Four differentiated epithelial cell types reside within the small 
intestinal epithelium: enterocytes, enteroendocrine cells, goblet cells, and Paneth cells.  
Enterocytes are absorptive cells that cover the intestinal villi.  Enteroendocrine cells 
and goblet cells are scattered among enterocytes and function as hormone and mucus 
secreting cells, respectively.  Paneth cells migrate to the bottom of crypts and secrete 
bactericidal defensins and lysozymes (Fig 1.4).  The colon has a similar structure as 
the small intestine, but the surface epithelium contains crypts without villi, and Paneth 
cells are not present (92-97).   
 
In addition to its role as a physical boundary, intestinal epithelial cells are important 
for immune modulation in the gut (98, 99).   The intestinal environment contains up to 
1014 commensal bacteria from an estimated 500–1000 different species (100).   
Therefore, in order to maintain a symbiotic relationship, the intestinal environment has 
evolved to become tolerized to the heavy bacterial load by signaling the immune cells 
(stromal cells, B cells, T cells, macrophages, and dendritic cells) underlying the 
epithelium (101-103).   Intestinal dendritic cells (DC) in the lamina propria are 
antigen-presenting cells that are non-inflammatory against commensal bacteria and 
food antigens, but are immunogenic to pathogen infections (104, 105). Intestinal 
epithelial cells regulate the function of mucosal DCs, and the epithelial cells are in 
turn controlled, at least in part, by commensal bacteria (106-109).  Under normal 
(steady-state) conditions, intestinal epithelial cells and commensal bacteria contribute  
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Figure 1.4.  Illustration of the intestinal epithelial barrier.   The small intestine is 
covered with a single layer of epithelial cells organized into villi and crypts.  The 
epithelial cells are differentiated into 4 functional subtypes:  absorptive encerocytes, 
hormone secreting enteroendocrine cells, mucus secreting goblet cells, and Paneth 
cells that produce antimicrobial peptides.   The follicle associated epithelium overlies 
the Peyer’s patch and lymphoid follicles, and within the follicle associated epithelium 
are M cells, which specialize in that uptake of luminal antigens. 
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to a Th2-polarizing response, as well as inducing regulatory T cells (Tregs) and IgA-
producing plasma cells.During infection, the intestinal DCs are involved in the 
induction of effector lymphocytes such as Th1 and Th17 cells (104, 110, 111).    
Previous studies have proposed that these different responses are driven by different 
DC subsets in the mucosa.  The non-inflammatory resident DCs express 
CD11c+CX3CR1+, and the inflammatory DCs located in the Peyer’s patch express 
CD11c+CCR6+ (110-112).  The mechanism of how intestinal epithelial cells 
distinguish non-pathogenic or pathogenic microbes and release appropriate cytokines 
is unknown; however, it is clear that intestinal epithelial cells play a key role in 
regulating mucosal immune response.  Intestinal epithelial cells sample luminal 
antigens in several ways.  The follicle-associated epithelium, which covers the Peyer’s 
patches and lymphoid follicles, contains microfold (M) cells which transcytose 
luminal antigens to DCs in the subepithelial dome (113, 114).   DCs can also directly 
sample antigens and microbes through dendritic processes extended between epithelial 
tight junctions, a process dependent on DC expression of CX3CR1 (115).   
 
Intestinal epithelial cells also serve as sensors for microbial infection.  Pathogenic 
microbes and their products activate signaling pathways in intestinal epithelial cells 
and induce the secretion of chemokines and cytokines for the attraction and activation 
of DCs, macrophages, neutrophils, lymphocytes, mast cells, and eosinophils (116).   In 
the case of T. gondii infection, intestinal epithelial cells initiate a series of innate 
immunologic events that lead to a robust inflammatory process in the gut.  Tissue 
samples from the small intestine of T. gondii infected mice have increased chemokines 
including monocyte chemotactic protein 1 (MCP-1/CCL2)), macrophage 
inflammatory protein 1! and " (MIP-1!/CCL3, and MIP1-"/CCL4), and MIP-
2/CXCL2, chemoattractants for DCs, macrophages, neutrophils, and T cells, 
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respectively (117).   However, T. gondii infection in certain strains of inbred mice 
leads to uncontrolled immunopathology during acute infection, which will be 
discussed in detail in the next few sections.  
 
6.  Toll-like receptor signaling in the intestinal epithelium 
Toll-like receptors (TLR) are pattern recognition receptors that detect microbes 
through specific recognition of microbial structures called pathogen-associated 
molecular patterns (PAMPs) (118) from bacteria, fungi, viruses, and protozoa. TLRs 
are structurally similar with an ectodomain containing leucine-rich repeats (LRR) for 
ligand binding, a transmembrane domain, and an intracellular domain containing the 
Toll/IL-1 receptor/resistance (TIR) domain for signaling.  TLRs are expressed at the 
cell membrane (TLR-1, -2, -4, -5, and -6) or localized in endosomes (TLR-3, -7, -8, 9).  
To date, 10 TLRs in humans and 13 TLRs in mice have been identified.  TLRs 1 to 9 
are conserved among humans and mice, but TLR10 is functional only in humans, and 
TLR11 is functional only in mice (119-121).  TLR2 forms heterodimers with TLR1 
and TLR6, and recognizes a wide spectrum of microbial components, including 
lipoproteins, lipoteichoic acid, lipoarabinomannan, GPI anchors, phenol-soluble 
modulin, zymosan, glycolipids, and peptidoglycan from various pathogens (122-125).  
TLR4 recognizes bacterial LPS (126), and TLR5 recognizes bacterial flagellin (127).  
TLR3 and TLR7-9 are intracellular receptors that recognize double-stranded RNA, 
single-stranded RNA, and bacterial CpG DNA respectively (120, 128-132).  More 
recently, mouse TLR11 is identified to recognize T. gondii profilin (133, 134). 
 
Dimerization of TLRs activates signaling pathways through the cytoplasmic TIR 
domain.   MyD88 is an adapter protein that associates with the TIR domain and 
initiates signaling cascades after ligand binding to all TLRs except TLR3. TLR3 
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instead uses the adapter protein TRIF. TLRs initiate a signaling cascade resulting in 
activation of NF-!B, which induces inflammatory cytokines. However, activation of 
each individual TLR can result in difference of gene expression profile activation 
(119-121, 135). 
 
Primary intestinal epithelial cells of normal mucosa express TLRs 1-9 (136-138).  
Although TLRs are generally expressed at low levels, they are upregulated during 
intestinal inflammation (136, 139, 140).   Specifically within the intestine, TLR2, 
TLR4 and TLR5 are expressed by the follicle-associated epithelium as well as the villi 
and crypts of the small intestine (141).  However, the expression of TLR2 and TLR4 
are generally low in the intestinal epithelial cells (136).  Further, TLR localization is 
restricted within intestinal epithelial cells.  For example, human intestinal epithelial 
cells express TLR5 at the basolateral surface (142), whereas mouse cells express 
functional TLR5 at the apical surface (143). Lee and colleagues showed that, in 
polarized intestinal epithelial cells, TLR9 is expressed at both the apical and 
basolateral surface (144).  This is in contrast to the endosomal localization described 
for TLR9 in immune cells. Interestingly, the localization is important for cellular 
response to CpG in epithelial cells since apical stimulation inhibited NF-!B signaling, 
whereas basolateral stimulation activated NF-!B signaling (144).   
 
TLRs expressed in epithelial cells were initially thought to be hyporesponsive to their 
ligands (137).  However, several studies have now demonstrated that epithelial cells 
require TLR signaling to maintain a healthy intestinal environment (102, 145, 146).  
Rakoff-Nahoum and colleagues have shown that TLR/MyD88 signaling in intestinal 
epithelial cells is crucial for gut homeostasis and protection against experimental 
induced epithelial injury and associated mortality (145). In the Peyer’s patch, TLR2, 
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TLR4, and TLR5 stimulation in the follicle-associated epithelium can increase uptake 
of luminal antigens and promote antigen capture by subepithelial DCs (141).  TLR2 
stimulation in polarized intestinal epithelial cells triggers redistribution of the tight 
junction protein ZO-1, and phosphorylation of protein kinase C (PKC) for the 
biogenesis of tight junctions (147, 148). Paneth cells also respond directly to bacterial 
PAMPs and increase the expression of antimicrobial peptides (149). Furthermore, 
TLR9 stimulation induces Paneth cells degranulation (150).  Bacterial stimulation 
through TLRs in epithelial cells induces the secretion of thymic stromal lymphopoietin 
(TSLP), TGF-!, and IL-25, which can decrease TLR responsiveness in dendritic cells, 
and limit development of Th1 and Th17 responses (151-153).  TLR stimulation of 
epithelial cells also induces the cytokine APRIL (a proliferation of inducing ligands), 
which promotes plasma cell survival and class switching from IgA1 to IgA2 (154).  
Goblet cells secrete trefoil factor 3 (TFF3), a peptide that is important in wound 
healing of the intestinal epithelium, when stimulated through TLR2 (155). 
 
7.  The role of TLRs and mucosal defense against T. gondii infection 
The importance of TLRs in host defense against T. gondii infection was first 
demonstrated in MyD88 deficient mice. Mice that lack MyD88 did not survive 
intraperitoneal (i.p.) infection due to uncontrolled parasite replication, and insufficient 
production of IL-12 and IFN-" (156). During oral infection, MyD88 deficient mice 
also display defects in neutrophil recruitment, T cell IFN-" secretion, and p47 GTPase 
IGTP (Irgm3) induction (157). MyD88 is a shared adapter protein for TLR and IL-1 
and IL-18 receptors and phenotypes observed in MyD88 deficient mice could be due 
to either failure in TLR signaling, or in either IL-1 or IL-18 receptor signaling (158).  
However, mice deficient in the interleukin-1b converting enzyme, which lack 
functional IL-1 and IL-18, survived infection (159). Therefore, the phenotype 
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observed in the MyD88 deficient mice is most likely due to lack of TLR signaling 
(159).   
 
Infection of individual TLR deficient mice revealed that multiple TLRs are important 
for host defense against T. gondii infection.  In the case of TLR4, two groups have 
reported contradicting results.  In one study, oral infection of C3H/HeJ mice, which 
encode a missense mutation in the TLR4 gene that destroys signaling, were more 
susceptible to oral infection. These mice displayed increased cyst numbers, reduced 
cytokine production, and enhanced pathology (160). In contrast, another group showed 
that TLR4-/- mice displayed reduced mortality (161).  TLR2!4-/- and TLR11-/-mice 
survived oral infection, but showed higher cyst numbers in the brain (162).   In 
addition to TLR2 and TLR4, TLR11 plays an important role in IL-12 production by 
DC in response to the T. gondii protein profilin (163).  Surprisingly, TLR11 is 
dispensable for IL-12 production during oral infection (162).  Lastly, T. gondii 
infection in TLR9-/- mice resulted in higher parasite burden and reduced IFN-! 
production, suggesting that TLR9 is also required for development of effective T cell 
responses (164).  
 
Oral infection with T. gondii induces severe intestinal inflammation and early 
mortality in C57BL/6 mice but not in BALB/c mice. The difference in disease 
outcome is reportedly associated with the H-2 complex. Mice with the H-2a haplotype 
are resistant, whereas mice with the H-2b haplotype are susceptible to oral infection 
(165).  In the case of C57BL/6 mice, at 7 days post infection there is massive necrosis 
of the villi, as well as infiltration of DCs, macrophages, neutrophils, and lymphocytes 
(74).  Excessive Th1 responses in susceptible C57BL/6 mice contribute to 
immunopathology mediated by CD4+ T cells (74). Recent studies have proposed that 
  19 
the commensal flora contribute to Th1 cytokine production because less pathology 
was observed in mice lacking bacterial sensing TLRs (TLR2, TLR4, and TLR9) (162, 
164).  More recent studies have shown that T. gondii oral infection causes CCR2-
dependent expansion in CD103+ intestinal epithelial lymphocytes (IEL), which 
possess pathologic activity during infection (166). 
The mucosal epithelium plays an important role in initiating protective response 
during T. gondii infection.  Following T. gondii oral infection, the parasite can be 
found in the small intestinal epithelium, lamina propria, and Peyer’s Patches within 1 
hour (167).  This suggests that the parasite may infect the mucosal surface by direct 
invasion of epithelial cells.  Yet, while studies have shown that high virulent T. gondii 
can utilize the host intercellular adhesion molecule (ICAM-1) for transmigration 
across the cellular barrier and dissemination (168), several lines of evidence suggests 
that intestinal epithelial cells can respond to T. gondii infection.  In vivo studies have 
shown that T. gondii infection can induce innate immune responses such as production 
of antimicrobial peptides in Paneth cells (169). In vitro studies by Mennechet and 
colleagues have also demonstrated that the small intestinal epithelial cell line (mICc12, 
H2-b haplotype) synergizes with lamina propria CD4+ T cells to enhance 
proinflammatory responses to T. gondii (117). 
 
8.  Brief outline of dissertation research 
The immune response elicited by infection with T. gondii involves both humoral and 
cell based immunity.  While systemic responses have been extensively investigated, 
the knowledge regarding the local immune responses in the gut during the acute phase 
of infection is limited. Chapter 2 reports the finding of early response of human 
intestinal epithelial response during T. gondii infection.  In this chapter, I used an in 
vitro model to demonstrate that T. gondii infection in epithelial cells elicits different 
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inflammatory responses and pathways and identified TLR2 as a receptor involved in 
recognition of T. gondii.   In Chapter 3, I examined how oral infection with T. gondii 
modulates the intestinal environment.  I found that T. gondii oral infection in wild type 
and TLR2 deficient mice result in differences in goblet cell and Paneth cell numbers, 
as well as different pathology.  Furthermore, T. gondii induced the movement of DCs 
to the follicle-associated epithelium in a TLR2 dependent fashion.   This finding has 
led me to identify TLR2 dependent molecules derived from T. gondii. In Chapter 4, I 
found that supernatants from T. gondiii infected cells contain parasite-derived factors 
that trigger epithelial transport of luminal antigens and a TLR2-dependent movement 
of DC to the follicle-associated epithelium.  Analysis of the supernatant revealed 
several T. gondii proteins, including 2 GPI-anchored proteins (SAG-1 and subtilisin) 
that are candidate TLR2 ligands. I found that supernatants from SAG1-deficient 
parasites had reduced TLR2 stimulatory activity.  Finally, Chapter 5 summarizes my 
results, discusses the significance of my findings, and suggests future directions for 
this research area. 
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Abstract 
The innate immune response of mucosal epithelial cells during pathogen invasion 
plays a central role in immune regulation in the gut.   Toxoplasma gondii (T. gondii) is 
a protozoan intracellular parasite that is usually transmitted through oral infection. 
Although much of the information on immunity to T. gondii has come from intra-
peritoneal infection models, more recent studies have revealed the importance of 
studying immunity following infection through the natural per-oral route.  Oral 
infection studies have identified many of the key players in the intestinal response; 
however, they have relied on responses detected days to weeks following infection.  
Much less is known about how the gut epithelial layer senses and reacts during initial 
contact with the pathogen.  Given the importance of epithelial cells during pathogen 
invasion, this study uses an in vitro approach to isolate the key players and examine 
the early response of intestinal epithelial cells during infection by T. gondii.  We show 
that human intestinal epithelial cells infected with T. gondii elicit rapid MAPK 
phosphorylation, NF-!B nuclear translocation, and secretion of interleukin (IL)-8.   
Both ERK1/2 activation and IL-8 secretion responses were shown to be MyD88 
dependent and TLR2 was identified to be involved in the recognition of the parasite 
regardless of the parasite genotype.  Furthermore, we were able to identify additional 
T. gondii-regulated genes in the infected cells using a pathway-focused array.  
Together, our findings suggest that intestinal epithelial cells were able to recognize T. 
gondii during infection, and the outcome is important for modulating intestinal 
immune responses.   
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Introduction 
A single layer of intestinal epithelial cells that line the mucosal surface must prevent 
the entry of exogenous antigens, allow absorption of essential nutrients and yet initiate 
effective and appropriate immune responses when pathogens are present (1).   Host 
defenses at mucosal surfaces include the secretion of IgA, defensins, and cytokines 
and chemokines.  IgA and defensins prevent bacterial adherence and contribute to 
pathogen elimination, while cytokines and chemokines participate in gut homeostasis 
as well as recruitment of immune cells during infection.  Epithelial cells express 
several innate immune receptors including nucleotide oligomerization domain (NODs) 
proteins and Toll-like receptors (TLRs) that participate in initiating the immune 
response (2).  However, activation is tightly controlled to prevent pathology due to 
mucosal inflammation (2-6).  Upon encounter with pathogenic bacteria, epithelial cells 
elicit a potent response that shapes the ensuing immune response (7, 8) 
 
T. gondii is an orally acquired apicomplexan protozoan parasite (9).   Human 
infections are usually asymptomatic, but reactivation of chronic infection in 
immunosuppressed individuals results in toxoplasmic encephalitis (10, 11).  
Serological surveys have estimated that one third of the world’s population has been 
exposed to this parasite (12).  However, there is no vaccine and therapeutic treatment 
regimens have significant side effects.   T. gondii infections are controlled primarily 
by T lymphocytes.  IL-12, and TNF-!, are critical cytokines for stimulating Th1 CD4+ 
T cell induced protection (13, 14), while interferon gamma (IFN-") plays a major role 
in protection through CD8+ T cells (14, 15). 
TLRs are innate immune receptors that directly recognize microbial structures and 
initiate an inflammatory response.  All TLRs, except TLR3, use the adapter molecule 
MyD88 to initiate the signaling cascade.  MyD88 deficient mice are highly susceptible 
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to T. gondii infection due to a failure to produce IL-12 (16).  Multiple TLRs have been 
linked to protective immunity against T. gondii infection.   In mice, TLR11 expressed 
by DCs is required for secretion of IL-12 in response to stimulation with the T. gondii 
protein profilin (17, 18).   TLR2 deficient mice show increased susceptibility with 
high dose intraperitoneal infection (19).  Oral infection of mice results in intestinal 
inflammation, ileitis, in wild type but not mice deficient in TLR9 or TLR4 (20, 21).  
This suggests that TLR9 and TLR4 may play a much more important role in initiating 
immunity to T. gondii at the mucosal surface.  The role of TLRs in human cell 
recognition of T. gondii infection is much less well studied.  Human TLR2 can 
respond to glycosylphosphatidylinositols (GPIs) from T. gondii, but the role of TLRs 
during live infection of human cells, especially in the gut has not been studied.    
 
T. gondii can infect the gut mucosa by direct invasion of epithelial cells in the small 
intestine (22).  Therefore, epithelial cells may respond directly to T. gondii infection 
and initiate early local mucosal immune responses.  This is supported by in vitro 
RNase protection studies using an immortalized mouse small intestinal enterocyte cell 
line, which demonstrated that the chemokines MCP-1, MIP-1 and eotaxin were 
induced upon infection (23).   In the present study, we have investigated whether 
human intestinal epithelial cells respond directly to infection with T. gondii and by 
what mechanism this recognition occurs.    
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Materials and Methods 
Cell culture and parasites 
Henle 407 (human embryonic intestinal epithelial cells), HEK293 (human embryonic 
kidney cells), and HS27 (human foreskin fibroblast) were maintained in Dulbecco’s 
modified Eagle’s medium (DMEM) supplemented with containing 2 mM L-
glutamine, 50 units/ml penicillin, 50 !g/ml streptomycin, 10 mM HEPES, 1 mM 
sodium pyruvate, and 10% low endotoxin fetal bovine serum.   T. gondii tachyzoites 
strain were maintained by serial 2 days passages on HS27 monolayers in DMEM.   All 
cell cultures and parasites were routinely checked for mycoplasma by a high 
sensitivity PCR-ELISA based Mycoplasma detection kit (Roche, Indianapolis IN).   
 
In vitro infections 
T. gondii tachyzoites were added to Henle 407 cells and were briefly centrifuged (400 
" g, 1 min) to initiate parasite and cell contact.  At time points indicated in each figure 
legend, supernatants or cell lysates were collected for further analyses.  In some 
experiments, 50 ng/mL wortmannin (WM) was added 2 hours prior infection.   
 
In vivo passage of T. gondii tachyzoites 
To pass the parasite through mice, C57BL/6 mice were infected with 5x104 RH 
tachyzoites by intraperitoneal (i.p.) infection.   After 3 days of infection, the parasites 
were collected from the peritoneal fluid and washed once with HBSS.   The parasites 
were then expanded by one additional passage in HS27 fibroblast prior stimulation.   
 
Antibodies 
Abs specific to total and phosphorylated forms of ERK1/2, p38, and PKB (Akt) were 
from Cell Signaling Technology (Danvers, MA).   Anti-MyD88 polyclonal Ab was 
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from Alexis Biotechnology (San Diego, CA).  NF-!B p65 antibody was from Santa 
Cruz Biotechnology, Inc (Santa Cruz, CA), and AlexaFluor 594 was from Molecular 
Probes (Invitrogen, Carlsbad, CA).  Anti-IL-18 antibodies were purchased from 
Abcam (Cambridge, MA) 
 
NF-!B translocation assay 
For immunofluorescence analyses, Henle 407 cells were plated at a number of 2-3 ! 
105 cells per well on sterile coverslips placed wells of a 24-well plate.   Cell 
monolayers were infected with T. gondii RH-YFP tachyzoites and were then fixed 
with 3% paraformaldehyde in PBS for 20 min at room temperature.  Fixed cells were 
permeabilized with 0.1% Triton X-100 in TBS (TBS-TX) for 15 min and blocked in 
1% BSA in TBS-TX for 20 min.  The cells were then stained with primary rabbit anti- 
NF-!B p65 followed by secondary antibody goat anti–rabbit IgG conjugated to 
AlexaFluor 594.  Nuclei were stained using DAPI.   Confocal images were taken with 
a Leica SP5 laser scanning confocal microscope using a 63!lens.  Contrast and 
brightness of individual channels were adjusted linearly in Photoshop (Adobe).   For 
immunoblot analyses, Henle 407 cells were plated at a number of 1.5 ! 106 cells per 
well in 6-well plate and infected with T. gondii RH for the indicated times.  
Cytoplasmic and nuclear proteins were isolated according to previous protocols (24) 
and blotted for p65 (1:500).   
 
RNA interference 
SureSilencing human MyD88, TLR2, and TLR9 shRNA and control plasmids were 
purchased from SuperArray Bioscience Corp (Frederick, MD).   Henle 407 cells were 
transfected using TransIT Transfection Reagent (Mirus Bio, Madison, WI) according 
to manufacturer's protocols.  Transfected cells were selected with neomycin (1.0 
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mg/mL) for 14 days, and antibiotic-resistant individual colonies were isolated for 
further analysis and maintained in the presence of neomycin.  For transient 
transfections, Henle 407 cells were transfected with shRNA plasmids by 
electroporation.  Cells were used at 48 to 96 hr post transfection.  
 
RNA extraction and PCR analysis  
Total RNA of Henle 407 cells infected with T. gondii was extracted using the RNeasy 
mini kit (QIAGEN, Valencia, CA).   Reverse transcription of the RNA (1 µg) was 
performed using ImProm-II™ Reverse Transcription System (Promega, Madison, 
WI). PCR was performed in 25 !L of a reaction mixture containing 1 !L of the 
reverse-transcribed RNA.  The final PCR products were electrophoresed on 2% 
agarose gels and visualized using UV light illumination after ethidium bromide 
staining. Real-time PCR was performed in the Applied Biosystems 7500 Real-Time 
PCR System (Applied Biosystems Inc., Foster City, CA) according to the manufacture 
instructions.  The reaction was performed using the Power SYBR Green PCR Master 
Mix.  Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as internal 
controls for each sample.   The primers sequences are listed in Table 2.1.  TLR and 
GAPDH primers are used as previously described (25, 26). 
 
Luciferase reporter assays 
HEK293 cells were plated at 1 x 104 cells/well in 96-well plates.  Cells were 
transfected using TransIT Transfection Reagent (Mirus) and a total of 200 ng 
DNA/well consisting of human TLR2 plasmids, and NF-!B or IL-8 luciferase 
reporters.  Cells were stimulated with TLR2 ligand, or infected with T. gondii 
tachyzoites, lysed in reporter lysis buffer (Promega), and assayed for luciferase 
(Promega) activity.  NF-!B activity was calculated and processed by Microsoft Excel.   
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Gene array analysis 
The commercial pathway-focused oligonucleotide microarray (OHS-011, Human 
Inflammatory Cytokines & Receptors Microarray) was purchased from SuperArray 
Bioscience Corp.   The array analyses were performed using a chemiluminescence-
based detection system according to the manufacturer's instructions.  Images of the 
array were developed on X-ray films.   Image data sets were scanned and analyzed 
using ScanAlyze (Eisen Lab), and Microsoft Excel software.  Background adjustment 
was performed by subtracting the lowest measured value on the membrane from the 
values of all genes.  The signals from the expression of each gene on the array were 
normalized against the signal from the internal housekeeping gene GAPDH to obtain 
the processed data sets.   Fold changes were calculated as the normalized ratio of 
average experimental processed data sets divided by the average medium control 
processed data sets.  Thresholds were set to select for genes up-regulated two fold or 
more.  The original array data were deposited in National Center for Biotechnology 
Information GEO database under accession number GSE18085.  
 
Cytokine ELISA 
Production of IL-8 was measured with the human CXCL8/IL-8 DuoSet ELISA 
Development Kits (R&D Systems, Minneapolis, MN) according to the manufacturer’s 
instructions.   
 
Statistical Analysis 
Minitab® 15 Statistical Software (Minitab, State College, PA) was used for Student's t 
tests.   A p value of < 0.05 was considered significant. 
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Table 2.1.  PCR primers used in this study. 
 
Gene Forward Reverse 
IL-8 AGC CTT CCT GAT TTC TGC AGC 
TCT 
AAT TTC TGT GTT GGC GCA GTG 
TGG 
CCL20 AGT TTG CTC CTG GCT GCT TTG 
ATG 
CTG CCG TGT GAA GCC CAC AAT 
AAA 
CCL15 TTG GAT CCC AGG CCC AGT TCA 
TAA 
AGC  AGT CAG CAG CAA AGT 
GAA AGC 
CCL24 ATG CCT CAA GGC AGG AGT GAT 
CTT 
TCT TCA TGT ACC TCT GGA CCC 
ACT 
MyD88 AGA TGA TCC GGC AAC TGG 
AAC AGA 
AGT CAC ATT CCT TGC TCT GCA 
GGT 
TLR1 GGC TGG CCT GAT TCT TAT AA CTC TAG GTT TGG CAA TAA TTC 
A 
TLR2 TCC AGC ACA CGA ATA CAC AGT ATT GCC ACC AGC TTC CAA AG 
TLR3 TGC AGC TGA CTA GGA ACT CCT 
T 
TGC TGC AAA TCG AGA ATT TC 
TLR4 TAA TAT TGA CAG GAA ACC CC TTC ATA GGG TTC AGG GAC AG 
TLR5 CCT TTT ATC GTT TCT GCA AC GCA TCT GGA TGC AAG AAG TA 
TLR6 GCT CTT TTG GGC TAA CAT TA AGA CTG GGC TGT CTC TAA CT 
TLR7 AGA TAA CAA TGT CAC AGC CG AGT TTT GGG ACA GAT CCA GT 
TLR8 AAA CAA ACT ACT CTT TTT AAC 
TG 
AAT TTT GAC ATT CAG ATG TT 
TLR9 GGA GGC TGG ATG TCA GCT GCA 
A 
CAG GCG CAG TGC AGA GGG TT 
TLR10 TCT TTA GTA AGT TGC TTT GC CAG GGA GAT CAG TTA GAA AA 
GAPDH GAA GGT GAA GGT CGG AGT C GAA GAT GGT GAT GGG ATT TC 
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Results 
Intestinal epithelial cells respond to T. gondii infection in vitro 
Oral infection with T. gondii results in ileitis in C57BL/6 mice mediated by a robust 
Th1 type of response (23).   CD4+ T cells synergize with intestinal epithelial cells to 
drive the secretion of Th1 type cytokines and various chemokines.  The response of 
intestinal epithelial cells directly to the parasite during the early stage of infection in 
mouse, and especially in human, remains unclear.  To determine if human intestinal 
epithelial cells respond directly to T. gondii, we incubated T. gondii tachyzoites (RH 
strain) with human intestinal epithelial cell lines.  Consistent with other studies on 
large intestine, colon cell lines did not activate mitogen-activated protein kinases 
(MAPKs) in response to T. gondii infection even though they were permissive for 
infection.   T. gondii were also able to infect the human small intestinal epithelial cell 
line Henle 407 (Fig. 2.1).   The kinetics of infected Henle 407 cells showed increased 
parasite invasion during the first few hours, followed by parasite replication after 8 
hours as indicated by the appearance of rosettes (Fig. 2.1 arrows).   Unlike colon cell 
lines, which have high levels of basal MAPK phosphorylation, T. gondii infection of 
Henle 407 cells induced phosphorylation of both ERK1/2 and p38 MAPKs by 15 
minutes (Fig. 2.2A).  ERK1/2 and p38 phosphorylation decreased at 30 minutes and 
was reduced nearly to baseline by 45 minutes.    
 
NF-!B regulates proinflammatory and anti-apoptotic genes in response to pathogens. 
To determine whether T. gondii infection of Henle 407 cells results in activation of 
NF-!B, we infected the cells for various times with RH tachyzoites and 
immunoblotted cytosolic and nuclear extracts for p65 NF-!B. Translocation of NF-!B 
to the nucleus was observed as early as 15 minutes, peaked at 60 minutes, and was still 
detected two hours post infection (Fig. 2.2 C). 
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Figure 2.1.  In vitro infection of Henle 407 cells.  Henle 407 cells were plated on 
cover slips and infected with RH-YFP T. gondii tachyzoites.  At each indicated time, 
cells were fixed with 3% paraformaldehyde and observed under 40X objective.   
Arrows indicate parasite replicating rosettes forming as early as 8 hr post infection. 
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Figure 2.2.  Intestinal epithelial cells respond to T. gondii infection.   (A) 
Activation of MAPK in T. gondii infected Henle 407 cells.   Henle 407 cells were 
incubated with RH tachyzoites (parasite to cell ratio 6:1) for the indicated times.   
Whole cell lysates were collected for Western blot analysis by immunoblotting with 
antibodies against total and phosphorylated forms of ERK/1/2 and p38 MAPK.  (B) 
IL-8 secretion in T. gondii infected Henle 407 cells.   IL-8 levels in infected culture 
supernatants were collected at indicated time points and assayed by ELISA (triplicate 
assays, error bar = SD).   Experiments were performed 3 times with similar results.  *, 
p < 0.05 compared with IL-8 levels of uninfected cells.  C and D, translocation of NF-
!B to the nucleus.   Henle 407 cells were infected with RH or RH-YFP parasites for 
the indicated times.  NF-!B p65 localization was visualized by Western blot (C) or 
immunofluorescence staining (D) after probing with anti–NF-!B p65 (red).   In 
uninfected cells, p65 was present in the cytoplasm, and infection with T. gondii 
resulted in nuclear localization of p65.   
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Infection with transgenic parasites expressing YFP (yellow fluorescent protein) 
allowed the visualization of infected cells.  Staining for p65 NF-!B demonstrated that 
infected, but not uninfected, cells translocated NF-!B to the nucleus (Fig. 2.2 D).  
Early immune defense against T. gondii involves recruitment of several innate 
immune cell populations including neutrophils, macrophages, dendritic cells and 
eosinophils (27-30).  Neutrophils, recruited by IL-8 (CXCL1/KC, CXCL2/MIP-2, and 
CXCL5-6/LIX homologues in mice), are often the first cell type recruited to the area 
of infection and provide the initial source of IL-12 that triggers Th1 T cell mediated 
immunity (27, 31).  Therefore, we next tested if epithelial cells could participate in the 
recruitment of neutrophils by secreting IL-8 in response to T. gondii infection.   Henle 
407 cells produced significant levels of IL-8 at 12 hours after infection with T. gondii 
(Fig. 2.2 B).  IL-8 levels continued to rise up to 24 hours post infection.   Taken 
together these data demonstrate that human small intestinal epithelial cells directly 
respond to infection with T. gondii tachyzoites by activating MAPK and NF-!B 
signaling cascades as well as producing chemokines that actively participate in the 
innate immune response to T. gondii.   
 
T. gondii infected intestinal epithelial cells express several inflammatory genes  
Oral infection studies have demonstrated an increase in several cytokines and 
chemokines in response to T.gondii infection; however, the mixed population of the 
intestinal mucosa did not allow for the determination of the relative role that specific 
cell populations play in the production of these mediators.  To address the role of 
intestinal epithelial cells to modulate the cytokine environment early following 
infection, we used specific pathway arrays to identify cytokines and chemokines 
induced 4 hours after exposure to T. gondii.  At this time point most cells have become 
infected, but the parasites have not replicated.  Consistent with previous studies on late 
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responses, infected epithelial cells expressed higher levels of proinflammatory 
chemokines including macrophage inflammatory protein-1a (MIP-1!/CCL3) and -2 
(MIP-2/CXCL2), RANTES/CCL5, monocyte chemotactic protein-2 (MCP-2/CCL8), -
3 (MCP-3/CCL7), and INF-"-inducible protein-10 (IP-10) (Table 2.2).  The induced 
cytokines and chemokines included ones that induce neutrophil chemotaxis (IL-8, 
MIP-2/CXCL2), homing of mucosal DCs (CCL20), and migration of DCs to sites of 
infection (MIP-1!/CCL3 and RANTES/CCL5) (27) (32). Of note, IL-18, which 
enhances IL-12 mediated immune responses to T. gondii, was highly induced in 
infected epithelial cells (33-35).  Real-time PCR analysis confirmed the upregulation 
of several neutrophil and monocyte chemoattractants including IL-8, CCL15, CCL20, 
and CCL24 upon T. gondii infection (Fig. 2.3).  Together, these data demonstrate that 
human intestinal epithelial cells induce chemotactic and inflammatory mediators 
capable of modulating the local immune response early (minutes to hours) after 
infection.   
 
Epithelial cell response to T. gondii is PI-3 kinase independent 
T. gondii infection of mouse macrophages induces MAPK and protein kinase B (PKB, 
also known as Akt) activation through a Gi-dependent PI-3 kinase signaling pathway 
(36).   Similar to macrophages, phosphorylation of Akt occurred in Henle 407 cells 60 
minutes after T. gondii infection (Fig. 2.4 A).  The PI-3 kinase inhibitor wortmannin 
completely blocked T. gondii induced phosphorylation of Akt, but only slightly 
reduced the phosphorylation of ERK1/2 and p38 at 15 minutes and had no detectable 
effect on ERK1/2 at 60 minutes (Fig. 2.4 A). However, T. gondii infection of 
wortmannin treated cells still resulted in an induction of IL-8 secretion with similar 
fold induction as untreated cells (Fig. 2.4 B) Real-time PCR analysis demonstrate 
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Table 2.2.  Pathway specific microarrays revealed upregulation of several T. 
gondii induced inflammatory cytokines, chemokines, and receptors.   Henle 407 
cells were infected with RH parasites and total RNA were collected at 4 hr post 
infection.  RNA from infected and uninfected cells was compared using a pathway-
focused oligonucleotide microarrays containing 113 genes involved in the 
inflammatory response.   Genes that were upregulated 2 fold or more after infection 
are shown. 
 
 
 
Cytokines and cytokine receptors   Chemokines and chemokine receptors 
  Gene Genbank no.  Fold change  Gene Genbank no.  Fold change 
  Il3 NM_000588  10.5  Ccl3 NM_002983  3.9 
  Il8 NM_000584  2.3  Ccl5 NM_002985  4.7 
  Il9 NM_000590  2.5  Ccl7 NM_006273  2.7 
  Il11 NM_000641  2.2  Ccl8 NM_005623  3.2 
  Il12a NM_000882  2.3  Ccl11 NM_002986  5.9 
  Il18 NM_001562  8.5  Ccl13 NM_005408  3.8 
  Il1rn NM_000577  2.9  Ccl15 NM_032965  6.2 
  Il1r2 NM_004633  2.1  Ccl20 NM_004591  5.8 
  Il8rb NM_001557  2.9  Ccl23 NM_005064  4.5 
  Il13ra2 NM_000640  2.1  Ccl24 NM_002991  11.1 
  Il15ra NM_002189  3.9  Cxcl2 NM_002089  2.1 
  Il18r1 NM_003855  7.9  Cxcl3 NM_002090  3.6 
  Mif NM_002415  3.6  Cxcl10 NM_001565  5.6 
  Tnf NM_000594  2.9  Cxcl13 NM_006419  2.4 
  Others      Ccr2 NM_000648  2.5 
  Gene Genbank no.  Fold change  Ccr3 NM_001837 2.6 
  Cd40lg NM_000074  2.9  Ccr6 NM_004367  2.4 
  Cebpb NM_005194  3.4  Ccr7 NM_001838  3.1 
  Crp NM_000567  2.4  Ccr9 NM_006641  6.3 
  Edg3 NM_005226  6.7  Blr1 NM_001716  2.8 
  Rps27a NM_002954  2.8  Pf4 NM_002619  2.5 
  Spp1 NM_000582  4.4         
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Figure 2.3.  Cytokine and chemokine gene induction by T. gondii infection.   
Human IL-8, CCL15, CCL20, and CCL24 gene transcripts levels measured by Real-
Time PCR analysis of RNA collected 4 hours post T. gondii infection.   The data are 
normalized to GAPDH and compared against uninfected expression levels (REL, 
relative expression levels). 
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Figure 2.4.  T. gondii induced MAPK activation and IL-8 secretion in intestinal 
epithelial cells is PI 3-kinase signaling independent.  (A) Henle 407 cells were 
preincubated 2 hr with or without PI3-kinase inhibitor wortmannin (WM, 50 ng/mL) 
followed by infection with T. gondii (parasite to cell ratio 6:1).   At the indicated time 
points, cell lysates were collected for Western blot analysis.  Antibodies against 
phosphorylated forms of AKT and ERK1/2 were blotted simultaneously, and the same 
blot was srtipped and reprobed with antibodies against total ERK1/2.   (B) Henle 407 
cells were pretreated with or without wortmannin and infected with T. gondii as 
described above.   IL-8 levels in infected culture supernatants were collected at 24 
hours post infection and assayed by ELISA (triplicate assays, error bar = SD).  *, p < 
0.05 compared with IL-8 levels of uninfected cells.   (C) Henle 407 cells were 
pretreated with or without wortmannin and infected with T. gondii for 4 hours. 
Analysis of IL-8 and GAPDH transcripts was performed by Real-Time PCR.   
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that IL-8 mRNA upregulation was not affected by wortmannin in infected or 
uninfected cells (Fig. 2.4 C).  This suggests that while the steady state production of 
IL-8, but not mRNA production is dependent on PI-3 kinase, T. gondii induced 
upregulation is independent of PI-3 kinase.     
 
Epithelial cell response to T. gondii infection is MyD88 dependent 
TLR9 has been implicated in the host response to oral infection with T. gondii since 
TLR9 deficient mice fail to develop ileitis that is observed in wild type mice (21).  
Both hematopoietic and non-hematopoietic cells express TLR9, and experiments using 
bone marrow chimeras suggest that both compartments are critical for the host 
response.  However, it is unclear if non-hematopoietic cells, such as epithelial cells, 
respond directly to T. gondii through TLR9, or if the response is secondary to 
commensal bacterial leak into the lamina propria following damage to the epithelium 
(37-39). To determine if TLR9, or other TLRs, play a role in early response of 
epithelial cells to T. gondii, we depleted MyD88 from Henle 407 cells by stable 
expression of a short hairpin RNA (shRNA) against MyD88.  All TLRs, except TLR3, 
are dependent on MyD88 for signal transduction. Control shRNA transfected Henle 
407 cells expressed similar levels of MyD88 protein as non-transfected cells. 
However, cells transfected with the MyD88 shRNA expressed significantly less 
MyD88 protein, confirming the effect of the RNAi mediated knockdown (Fig. 2.5 A).  
Upon T. gondii infection, cells deficient in MyD88 had a significantly reduced level of 
ERK1/2 phosphorylation compared to control cells (Fig. 2.5 B).  Furthermore, MyD88 
deficient cells failed to induce IL-8 upon exposure to T. gondii (Fig 2.5 C).  MyD88 is 
also an adapter protein for IL-1 and IL-18.  Since IL-18 is induced upon T. gondii 
infection, and contributes to small intestinal pathology in C57BL/6 mice (33, 34), it 
remains possible that the MyD88 dependence is via IL-18 signaling.  However, in 
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Figure 2.5.   T. gondii induced MAPK activation and IL-8 secretion is MyD88 
dependent.  (A) Henle 407 cells were either untransfected (1), transfected with 
control shRNA plasmids (2), or MyD88 shRNA plasmids carrying the MyD88 RNA 
interference sequence (3).   Cell lysates from the stably transfected cell lines were 
collected for immunoblotting with antibodies against MyD88 or !-tubulin.   (B) 
Activation of ERK1/2 in T. gondii infected MyD88 knockdown Henle 407 cells.   
Control Henle 407 cells (1), control shRNA cells (2), and MyD88 shRNA cells (3) 
were infected with RH tachyzoites (parasite to cell ratio 6:1) at the indicated time 
points. Cell lysates were collected for immunoblotting with antibodies against total 
and phosphorylated forms of ERK1/2.   (C) Control Henle 407 (1), control shRNA (2), 
and MyD88 shRNA cells (3) were infected with T. gondii (parasite to cell 6:1).   
Supernatants from each sample were collected for IL-8 ELISA analysis.  (Triplicate 
assays, error bar = SD).   
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Henle 407 cells, the bioactive form of IL-18 was not detected until 6 hours post T. 
gondii infection (Fig 2.6).  This suggested that while IL-18 mRNA level is regulated 
after infection, the post-translational cleavage to generate the bioactive form of IL-18 
did not occur until later. Therefore, MyD88 plays a critical role in the response of 
Henle 407 small intestine epithelial cells to T. gondii infection most likely through a 
TLR.  
 
T. gondii activates TLR2 on intestinal epithelial cells  
Similar to other studies on primary human small intestine cells, Henle 407 cells 
expressed most of the TLRs except TLR8 (40) (Fig 2.7 A). Stimulation with TLR 
ligands, or phorbol-12-myristate-13-acetate (PMA) as a control, induced 
phosphorylation of ERK1/2 and p38 within 15 minutes (TLR1/2: Pam3Cys; TLR2/6: 
Malp-2; TLR3: polyI:C; TLR4: LPS; TLR5: flagellin; TLR7: loxoribine; TLR9: CpG 
DNA) (Fig. 2.7 B). To specifically identify which human TLR was involved in T. 
gondii recognition, we reconstituted HEK293 cells with each human TLR 
independently and measured activation of NF-!B following stimulation with positive 
control ligands, soluble Toxoplasma antigen (STAg) or live T.gondii infection using a 
luciferase reporter.   While each positive control ligand stimulated NF-!B activation in 
the respective TLR expressing cells, only TLR2 expression was permissive for NF-!B 
response to live T.gondii infection (Fig. 2.8 A). STAg failed to activate NF-!B, 
suggesting that live infection was required. To confirm the role of TLR2 in Henle 407 
cell response to T. gondii infection, we knocked down TLR2 expression using shRNA. 
Transient transfection with TLR2 shRNA depleted the mRNA relative expression 
levels to 6% of wild type (Fig. 2.8 B). 
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Figure 2.6.  The mature form of interleukin (IL)-18 is induced after 6 hours post 
infection.  Henle 407 cells were uninfected (control) or infected with RH tachyzoites 
(parasite to cell ratio 6:1) and cell lysates were collected at 4, 6, 8, 10, and 12 hours 
post infection. Immunoblot analysis was performed by immunoblotting with 
antibodies against IL-18 or !-tubulin.  The mature form of IL-18 is detected as early 
as 6 hours post infection.  
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Figure 2.7.  TLR genes are expressed in Henle 407 cells.   (A) Total RNA was 
collected from Henle 407 cells, reverse transcribed to cDNA and then amplified for 
human TLR or GAPDH by PCR (cDNA).  Genomic DNA was used as a positive 
control (gDNA control). (B) Henle 407 cells were treated with 10 ng/mL PMA as 
positive control or TLR1/2, TLR4, TLR2/6 and TLR9 ligands (1 µg/mL Pam3Cys, 
100 ng/mL LPS, 1 µg/mL Malp-2, and 5 µg/mL CpG respectively).   Total cell lysate 
were collected and immunoblotted for total and phosphorylated forms of ERK1/2 and 
p38.   
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Figure 2.8.   Human TLR2 is important for recognition of T. gondii.   (A) HEK293 
cells were transfected with different human TLRs and an NF-!B luciferase reporter 
plasmid.   The transfected HEK293 cells were stimulated with TLR ligands, STAg 
(soluble Toxoplasma antigen), or infected with live RH tachyzoites.   Cell lysates were 
collected and assayed for luciferase activity (Triplicate assays, error bar = SD).   (B-D) 
Henle 407 cells were transiently transfected with shRNA plasmids carrying TLR2 (2), 
MyD88 (M) RNA interfering sequences, or no DNA control (C). (B) TLR2 and 
MyD88 mRNA levels as measured by Real-time PCR. (C) Total cell lysates from cells 
infected with RH tachyzoites (parasite to cell ratio 6:1) for the indicated time points 
were immunoblotted with antibodies against total and phosphorylated forms of 
ERK1/2 and p38. (D) IL-8 levels from cells in B as measured by Real-time PCR 
following 4 hours infection with T. gondii RH tachyzoites. (E) HEK293 cells were 
transfected with TLR2 and an IL-8 promoter-luciferase reporter construct.  Luciferase 
activity from cells left in media alone (control), or infected with tachyzoites (RH 
strain).  Cells were pretreated with ERK1/2 inhibitor U0126, or DMSO as a solvent 
control, prior to infection. (Triplicate assays, error bar = SD) 
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Knockdown of TLR2 reduced the activation of ERK1/2, p38, and IL-8 induction in 
response to T. gondii infection (Fig. 2.8 C and D).  Transient transfection of MyD88 
shRNA gave similar results compared to stably transfected cells (Fig. 2.8 C and D 
compared to Fig. 2.5).  TLR2 knockdown in Henle 407 cells does not completely 
block the response of MAPK activation and IL-8 induction.  Therefore, the response is 
almost entirely MyD88 dependent, but only partially dependent on TLR2.  Attempts to 
combine TLR2 with other TLRs, including TLR4 and TLR9, in our HEK293 based 
stimulation assay did not result in further increases in NF-!B activation.  TLR2 was 
sufficient for IL-8 production since its expression in HEK293 cells permitted 
induction of an IL-8 regulated luciferase reporter (Fig. 2.8 E). Pretreatment with 
ERK1/2 inhibitor U0126 inhibited IL-8 luciferase. These data demonstrate that TLR2 
induced IL-8 production was through the ERK1/2 pathway (Fig. 2.8 E).  In our 
system, TLR9 was neither necessary nor sufficient for epithelial cell response to T. 
gondii infection (Fig. 2.9 and Fig. 2.8 A). Taken together, T. gondii induced IL-8 is 
dependent on ERK1/2, and MyD88, and that TLR2 is both necessary and sufficient for 
their response.  
 
Genotype of T. gondii does not influence epithelial cell response 
T.gondii strains have been classified into 3 clonal lineages that differ in their 
pathogenicity in mouse models (41).  Several strains of each clonal lineage were tested 
for their ability to induce epithelial cell response and activate TLR2.  Henle 407 cells 
phosphorylated ERK1/2 in response to all strains from each of the three lineages (Fig.  
2.10 A; Type 1: GT; Type 2: PT-G, CC, DEG; and Type 3: VEG).  The various strains 
differed dramatically in their capacity to induce phosphorylation of p38, but there was 
no correlation with genotype (Fig. 2.10. A).  All strains induced NF-!B activation 
through TLR2 (Fig. 2.10. B). The type I RH strain had a lower capacity to induce NF-
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!B when compared to another Type I strain, GT-1.  RH tachyzoites grown in cell 
cultures have reduced virulence when compared to those passaged in mice (42).  
Similarly, we observed that RH tachyzoites passaged in mice induced significantly 
more TLR2-dependent NF-!B activation than those passaged through fibroblasts in 
vitro. The ability of live T. gondii to activate cellular responses through TLR2 was not 
unique to human cells, since cells transfected with mouse TLR2 responded similarly 
(Fig 2.11). Together, we conclude that TLR2 dependent activation of signaling 
cascades by T. gondii is not genotype dependent. 
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Figure 2.9.  TLR9 was despensible for epithelial cell response to T. gondii.  (A) 
Henle 407 cells were either untransfected (no DNA control), transiently transfected 
with control shRNA plasmids (shRNa control), or TLR9 shRNA plasmids carrying the 
TLR9 RNA interference sequence (TLR9 shRNA).   TLR9 mRNA levels were 
measured by Real-time PCR.  (B) Total cell lysates from cells infected with RH 
tachyzoites (parasite to cell ratio 6:1) for the indicated time points were 
immunoblotted with antibodies against total and phosphorylated forms of ERK1/2. 
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Figure 2.10.   MAPK activation and TLR2 dependent response to T. gondii is not 
strain type specific.   (A) Henle 407 cells were infected with, GT-1 (Type I), CC, 
DEG (Type II), and VEG (Type III) T. gondii strains for the indicated time points.  
Total cell lysates were collected for immunoblotting with antibodies against total and 
phosphorylated forms of ERK1/2 and p38.  (B) HEK293 cells were transfected with 
human TLR2 and an NF-!B luciferase reporter plasmid.   The transfected HEK293 
cells were stimulated with TLR2 ligand Pam3Cys or infected with different T. gondii 
tachyzoite strains.   Cell lysates were collected at 18 hr and assayed for luciferase 
activity.  (Triplicate assays, error bar = SD). 
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Figure 2.11.   T. gondii activates both human and mouse TLR2.  HEK293 cells 
were transfected with an NF-!B luciferase reporter plasmid, pSV-!-galactosidase 
reporter plasmid, and human or mouse TLR2 plasmids.   The transfected HEK293 
cells were infected with different T. gondii tachyzoite strains.   Cell lysates were 
collected at 8 hr and assayed for luciferase and !-galactosidase activity.  NF-"B 
activity (relative light units, RLU) was calculated by dividing the luciferase counts by 
the control !-galactosidase. (Triplicate assays, error bar = SD).   
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Discussion 
In the present study, we evaluated the initial cellular responses of human intestinal 
epithelial cells to T. gondii infection.  This type of study is critical for identifying the 
very early innate immune responses to parasitic infection of the intestinal mucosa.  
Using an in vitro model, where an isolated cell type is directly exposed to the 
infectious agent offers the advantage over mixed cell populations in identifying the 
response of a specific cell type. Most studies on the immune response to T. gondii 
infection have used a peritoneal challenge model for this orally acquired pathogen.  
More recently, studying the natural route of infection has revealed the importance of 
epithelial cell response in influencing the outcome of the local and systemic immune 
response (43, 44).  Therefore, it is highly relevant to study the response of these cells 
during T. gondii infection, which occurs both locally in the intestine and systemically.   
 
Very little is known about the human intestinal response to T. gondii infection; 
therefore, a major finding of this study is that human small intestinal epithelial cells 
directly respond to T. gondii within minutes to activate signaling cascades. By 
examining the response of the cells most likely to first encounter the pathogen, we can 
begin to uncover the early responses that may limit, or induce, the spread of T. gondii 
to other tissues such as muscle and brain, where a persistent infection results.  
 
The neutrophil chemoattractant IL-8 is upregulated both at the protein and mRNA 
level within hours.  Several additional cytokines and chemokines are also upregulated 
at the mRNA level within 4 hours.  During mouse infections with T. gondii, 
neutrophils are critical for host defense and are one of the first cells recruited to the 
site of infection.  They play a key role in the recruitment and activation of 
macrophages and DCs (27, 31, 45).  Therefore, our findings that the human small 
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intestine epithelial cell line, Henle 407, directly responds to T. gondii infection 
suggests that in vivo epithelial response would modulate the local inflammatory 
environment to initiate host defense against infection.   
 
This series of studies also elucidates the molecular mechanism for epithelial response 
to T. gondii infection. We show that, similar to macrophages and DCs, epithelial cells 
activate the MAPK pathway.  The inability of MyD88 deficient epithelial cells to 
secrete IL-8 and activate ERK1/2 during infection suggests that TLRs play a critical 
role in the initiation of mucosal inflammatory process. Human TLR2 responds to live 
T. gondii infection in our heterologous reconstitution assay.  However, knocking down 
TLR2 with short hairpin RNAs in intestinal epithelial cells only partially reduced the 
activation of ERK1/2.  So while TLR2 contributes to epithelial response to T. gondii 
infection, there is likely an interaction with additional TLRs or other receptors that we 
could not detect in our assay.  In fact, preliminary examination of the dependence of 
several cytokines and chemokines on MyD88 and TLR2 using shRNA knockdown 
revealed a complex pattern. While several genes were TLR2 dependent (IL-8, CCL10, 
CCL15), a few were TLR2 independent, MyD88 dependent (CCL5 (RANTES) and 
CCL11).  IL-18 and CCL20 did not depend on either MyD88 or TLR2. TLR4 and 
TLR9 are candidates to work in concert with TLR2 for the production of cytokines 
and chemokines since mice deficient in these TLRs have reduced intestinal pathology 
during oral T. gondii infection.  Furthermore, TLR9 in both hematopoietic and 
nonhematopoietic compartments is important for efficient T cell responses to oral 
infection (21).  However, in our in vitro system, knocking down TLR9 in Henle 407 
cells or reconstituting TLR9 in HEK293 cells does not affect MAPK or elicit NF-!B 
response to T. gondii.   Commensal bacteria are present in the intestine and are capable 
of activating TLR9 (46-48).  Therefore, it is likely that the TLR9 dependent pathology 
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induced during oral infection with T. gondii is secondary to epithelial damage and 
recognition by TLR9 of bacteria that penetrate the epithelial barrier.    
 
Ligands for TLR2 include lipopeptides, lipoproteins and GPIs.  GPI anchored proteins 
are abundant on the surface of T. gondii tachyzoites, and GPIs from Trypanosoma 
cruzi, Plasmodium falciparum activate TLR2 (49, 50).  T. gondii GPIs also stimulate 
cytokine production in macrophages through TLR2 and TLR4 (51, 52).  Direct studies 
on the role of TLR2 in human intestinal epithelial cells during T. gondii infection are 
lacking.  Our data suggest that activation of TLR2 requires live parasites, or at least 
components not present in STAg, or damaged or lost during the preparation of STAg.  
The molecular component of T. gondii that intestinal epithelial cells recognize via 
TLR2 remains unknown.   
 
The molecular mechanisms by which T. gondii activates epithelial cells and 
macrophages are different. In macrophages, T. gondii exploits Gi-protein mediated 
signaling to activate PI-3 kinase that leads to Akt and ERK1/2 activation, a process 
that is independent of MyD88 signaling (36). We show that inhibition of PI-3 kinase 
had no effect on the ability of epithelial cells to respond to infection. T. gondii 
infection of macrophages fails to induce NF-!B nuclear translocation and in fact 
inhibits activation in response to TLR ligands such as LPS (53, 54).  In epithelial cells, 
NF-!B translocation to the nucleus was not impaired. Similar results in infected 
murine embryonic fibroblasts (MEFs) have been reported (55, 56). Both ERK1/2 and 
p38 kinases were activated by T. gondii infection of epithelial cells; however, 
activation was almost entirely dependent on MyD88 but only partially dependent on 
TLR2. Additional innate immune receptors or other recognition mechanisms present 
in the intestinal epithelial cells may cooperate to regulate the immune response of T. 
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gondii infection. These other receptors are unlikely to be TLRs since attempts to co-
express other TLRs with TLR2 did not enhance the response in our HEK293 based 
stimulation assay. 
 
There are three clonal lineages of T. gondii that differ in their ability to induce 
cytokines and in virulence. Low virulence type II parasites show higher induction 
level of IL-12p40, IL-10, IL-1b, and IL-6, where as high virulence type I parasites 
attract more neutrophils during infection (57, 58). We predicted that ability to activate 
TLR2 might correlate with lower virulence due to an increased activation of the 
immune response especially since NF-!B activation and cytokine secretion in immune 
cells correlates with genotype (59). However, all types elicited ERK1/2 and p38 
MAPK activation through TLR2.  Although the strains varied in the level of 
activation, there was no correlation with genotype.   Virulence and cytokine induction 
differences among strains are not due to ability to activate epithelial cells via TLR2.    
In summary, this study demonstrates that human intestinal epithelial cells directly 
respond to T. gondii infection via MyD88 and TLR2 driven ERK1/2 kinase and NF-
!B signaling pathways. An interesting question for future studies is how epithelial 
cells cross talk and influence immune cells during infection. Our preliminary data 
point to a complex pattern of cytokine regulation, in which TLR2 is important but not 
the whole story. Understanding the local immune response against pathogens in the 
intestine will provide insight into the development of intestinal disorders, mechanisms 
for enhancing immune response to infection, or targets for vaccine development. 
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CHAPTER III 
TOXOPLASMA GONDII MODULATES THE LOCAL INTESTINAL 
ENVIRONMENT THROUGH TLR2 
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Abstract 
Toxoplasma gondii is an intracellular pathogen that infects the host through the oral 
route.  The intestinal epithelial layer not only functions as a physical barrier between 
the lamina propria and commensal microbes, but is also important for host defense 
during pathogen invasion.  The intestinal epithelium is composed of various cell types 
such as enterocytes, goblet cells, and Paneth cells.  We have previously shown a role 
for TLR2 in intestinal epithelial cells in initiating immune responses during T. gondii 
infection using an in vitro model.  This study describes the kinetics of T. gondii 
infection-induced modulation of the local intestinal epithelium.  Our study shows that 
oral infection with T. gondii causes TLR2 dependent pathology, as manifested by 
decreased numbers of goblet cells and Paneth cells, as well as secretion of Paneth cell 
granules to the crypt lumen.  RNA transcript analysis of the infected tissues 
demonstrates that in addition to the cytokines that were previously characterized to 
cause pathology in the gut, several chemokines involved in immune cell trafficking 
were also highly upregulated after infection.  By using a surgical ligated ileal loop 
model, subepithelial dendritic cells located in the Peyer’s patch were shown to migrate 
to the follicle-associated epithelium within 90 minutes after live parasite infection.   
These responses were not observed in TLR2 deficient mice.  In addition to DC 
migration, our in vitro studies using murine epithelial cell lines showed upregulation 
of the tight junction protein ZO-1 and defensin mRNA transcripts within 6 hours after 
T. gondii infection.  Taken together, our findings suggest that T. gondii infection 
triggers epithelial cell responses at different stages of infection.  These data support a 
model where TLR2 is important in modulating immune cell trafficking as well as 
inducing pathology. 
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Introduction 
The intestinal epithelium is important for maintaining gut homeostasis and initiating 
appropriate immune responses when encountering pathogens (1).  To perform their 
various functions, the epithelial cells consist of different subtypes.  Enterocytes are 
absorptive cells that are the most abundant cell type (2).  Goblet cells and 
enteroendocrine cells are found scattered throughout the epithelium and secrete 
mucins and hormones respectively (2).  Paneth cells are located at the base of the crypt 
and contain lysozymes and defensins packed in eosinophilic granules (2).  M 
(membranous or microfold) cells sample luminal antigens and are found near 
lymphoid structures including Peyer’s patches (2-10).   
 
Toll-like receptors (TLRs) are expressed by many cells types in the intestine and act as 
sensors for detecting conserved molecular PAMPs from both commensal and 
pathogenic microbes (11-15).   In healthy hosts, TLR signaling is essential and 
activated at basal levels to maintain epithelial integrity, cell proliferation, tolerance 
and regulation of mucosal immune functions (16-18).   The Peyer’s patch plays a 
central role in immune surveillance of the small intestine and is an important inductive 
site for mucosal immunity (19-21). The Peyer’s patch is covered with specialized 
follicle associated epithelium (FAE) containing M cells and enterocytes.  The FAE 
secretes various cytokines that attracts dendritic cells to the subepithelial dome (SED) 
(22-25).  In vivo studies have shown that stimulation with TLR agonists enhance M 
cell uptake and induce the migration of DC to the FAE (26-28). 
 
Toxoplasma gondii is an intracellular protozoan parasite that infects humans and 
animals worldwide (29, 30).   Transmission of this parasite is mostly through ingestion 
of contaminated soil or meat (31, 32).  Oral infection with T. gondii in susceptible 
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C57BL/6 mice results in severe inflammation in the small intestine.  This 
immunopathology is mainly caused by Th1 type CD4+ T cells, which mediate the 
increase in proinflammatory cytokines such as TNF-!, IFN-" and nitric oxide (33, 34).  
The characteristics of T. gondii induced ileal inflammation in these mice also resemble 
the acute phase of inflammatory bowel disease in humans (33, 35-37).   The 
mechanism of T. gondii induced Th1 pathology is thought to initiate through epithelial 
damage that leads to translocation of luminal bacteria (38-40).  In combination with 
DCs that have acquired T. gondii antigens, the bacterial triggered DCs produce IL-12 
and activate Th1 lymphocytes (39, 41).  Several mouse strains including TLR9 
deficient and TLR2!4 double deficient mice were shown to have less pathology but 
higher parasite burden (39, 42).   In TLR9 deficient mice, oral infection with T. gondii 
also resulted in decreased IFN-" production and release of a-defensins (cryptins) into 
the crypt lumen (43).  However, it is not known whether other TLRs participate in the 
recognition of T. gondii during infection.  Whether T. gondii infection directly 
regulates epithelial cell barrier integrity, defensin secretion or modulates the FAE 
function is also not known. 
 
In our previous study, we demonstrated that epithelial cells are involved in the 
recognition of T. gondii through TLR2.  Here, we ask how oral infection with of T. 
gondii elicits a response of the intestinal microenvironment at different stages of 
infection.   The result of infection by T. gondii may be caused by combination of 
direct or indirect consequences.  In this study, we focus on the direct response of the 
intestinal epithelial cells triggered by the parasite.  The role of TLR2 in initiating DC 
migration in the Peyer’s patch and subsequent parasite-induced pathology was 
characterized using TLR2 deficient mice.    
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Materials and Methods 
Experimental Animals 
MyD88+/+ and MyD88–/– mice originally generated by S. Akira (Osaka University, 
Osaka, Japan) and provided by Dr. Eric Denkers (Cornell University, Ithaca, NY) were 
generated by heterozygous breeding.  TLR2 -/- (Tlr2tm1Kir) on a C57BL/6 background 
and wild type (C57BL/6) mice were obtained from The Jackson Laboratory (Bar 
Harbor, ME).  Mice of both sexes were used at 8-12 weeks of age.  The mice were 
bred and housed under specific pathogen-free conditions at the Transgenic Mouse 
Core Facility, Cornell University College of Veterinary Medicine, overseen by the 
Institutional Animal Care and Use Committee.  
 
Parasite, cyst isolation, and oral infection 
Type II low-virulence T. gondii ME49 cysts were obtained from chronically infected 
Swiss Webster mice.  To obtain the brain cysts, animals were sacrificed and the brains 
were homogenized in sterile PBS.  The brain homogenate was passaged through an 
18G needle.  For oral infection studies, mice were gavaged with 20-30 cysts in a 
volume of 200 µl in PBS.  The weight of the mice was monitored daily and the 
percentage of weight loss was compared to the initial weight on day 0. 
 
Histochemical stains and microscopy 
Animals were sacrificed at 7 or 11 days post-infection. Small intestine tissues were 
collected, preserved in 10% neutral-buffered formalin, and submitted to the Histology 
Unit, College of Veterinary Medicine (Cornell University, Ithaca, NY) to be processed 
into paraffin-embedded blocks.  The tissue sections were cut with a microtome (5µm), 
and then stained with hematoxylin and eosin (H&E), periodic-acid Schiff (PAS) and 
Lendrum’s phloxine tartrazine (Lendrum’s) for identification of crypt-villus units, 
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goblet cells and Paneth cells respectively.  An AxioImager M1 microscope (Carl Zeiss 
MicroImaging, Inc.) was used to examine the sections and images were captured at 
20! or 63! objective (200! or 630! magnification) using an Axiocam HRc (Carl 
Zeiss MicroImaging, Inc.).  Villus length was quantified by measuring from the crypt-
villus junction to the apical cell surface at the tip of intact crypt-villus units using the 
length measurement function in the AxioVision Rel. 4.8 software (Carl Zeiss 
MicroImaging, Inc.).  Morphological differences were achieved by quantifying goblet 
cells per villus, Paneth cells per crypt, and granules per Paneth cell.  Measurements for 
each quantitative outcome were collected from 48 intact crypt-villus units analyzed 
from the distal to proximal ileum. 
 
Cell cultures and parasites 
The mICcl2 cells are mouse intestinal epithelial cells derived from the small intestine of 
a transgenic C57BL/6 mouse described previously (44).  Cells were grown in tissue 
culture flasks in a modified defined medium (DMEM/HAM’s F12 (1/1, v/v) 
supplemented with 2% fetal bovine serum, 5 µg/ml insulin, 10 ng/ml epidermal growth 
factor, 5 µg/ml human transferrin, 50 nM dexamethasone, 30 nM sodium selenate, 1 
nM triiodothyronine, 100 IU/ml penicillin-streptomycin, 1% fungizone, and 20 mM 
HEPES buffer at 37°C in 5.2% CO2/air atmosphere. Human foreskin fibroblasts 
(HS27) were maintained in Dulbecco’s modified Eagle’s medium (DMEM) 
supplemented with containing 2 mM L-glutamine, 50 units/ml penicillin, 50 µg/ml 
streptomycin, 10 mM HEPES, 1 mM sodium pyruvate, and 10% low endotoxin fetal 
bovine serum.   T. gondii tachyzoites strain were maintained by serial 2 days passages 
on HS27 monolayers in DMEM.   All cell cultures and parasites were testd negative 
for mycoplasma by a high sensitivity PCR-ELISA based Mycoplasma detection kit 
(Roche, Indianapolis IN).  
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Surgical ligated intestinal loops 
Mice were anesthetized by intraperitoneal (i.p.) injection of avertin (tribromoethanol in 
t-amyl alcohol; 200 mg/kg animal weight), and a 3- to 5-cm segment of ileum 
containing a Peyer’s patch was ligated and injected as protocols described previously 
(45).  Loops were injected with approximately 200 µl of complete DMEM or live 
parasites resuspended in complete DMEM. The animals were sacrificed after 90 
minutes, and Peyer’s patches were excised, washed in cold PBS, immediately 
embedded in Tissue-Tek OCT-embedding medium (Sakura, Torrance, CA), frozen in 
2-methylbutane (Sigma-Aldrich, St. Louis, MO) cooled with liquid nitrogen, and 
stored at –80°C until sectioned.  
 
Immunohistochemistry of frozen tissue sections 
Immunohistochemistry was performed on fresh frozen Peyer’s patch tissue sections.  
Cryosections (3-5 µm) of frozen Peyer’s patches were cut on a cryostat model Microm 
HM 525, mounted on Superfrost Plus microscope slides, air-dried overnight, and fixed 
with cold acetone for 2 minutes.  Cryosections were blocked using PBS containing 2% 
goat serum. The following primary antibodies were used: biotin-conjugated rat anti-
mouse CD11c (BD Pharmingen), and rabbit anti-mouse laminin (MP Biomedicals, 
Solon, OH).  As secondary reagents, the following were used:  streptavidin-Alexa-488 
or -647 for CD11c detection, and goat anti-rabbit-Alexa-488 or 647 (Invitrogen, 
Carlsbad, CA) for laminin detection.  All stained tissues were mounted with Prolong 
Gold antifade reagent containing DAPI (Invitrogen, Carlsbad, CA). 
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RNA extraction and Real Time PCR 
Total RNA were extracted using the RNeasy mini kit (QIAGEN, Valencia, CA) and 
DNase I treated.   The cDNA was synthesized from 1 µg of RNA using SuperScript III 
Reverse Transcriptase Kit with the supplied Olige-dT primers (Invitrogen, Carlsbad, 
CA). Real-time PCR was performed on the Applied Biosystems 7500 Fast Real-Time 
PCR System (Applied Biosystems, Foster City, CA) with the SYBR green detection 
reagent (40 cycles at 95°C for 10 s and at 60°C for 1 min).  Glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) was used as an internal control for each sample.  
Primers used in this study are designed as previous studies and listed in Table 3.1 (46-
48). Percentage of relative expression level (REL%) was calculated using the 2!""Ct 
method.  For infected tissue Real-time mRNA analysis, PCR arrays (PAMM-073, 
Th17 for Autoimmunity & Inflammation PCR Array) were purchased from 
SABioscience Corp.  The signals from the expression of each gene on the array were 
normalized against the signal from the internal housekeeping gene.   Fold regulation 
for each gene was calculated as the processed data set from infected sample divided by 
processed data set from uninfected sample.  Thresholds were set to select for genes up-
regulated 3 fold or more. 
 
Immunofluorscent staining of mICc12 cells and concofal microscopy 
Murine small intestinal mICc12 cells were plated at 2-3 # 105 cells per well on sterile 
coverslips placed in 24-well plates.   Cell monolayers were polarized for 6 days and 
infected with T. gondii RH-YFP tachyzoites apically.  The cells were fixed with 3% 
paraformaldehyde in PBS for 20 min at room temperature.  Fixed cells were 
permeabilized with 0.1% Triton X-100 in TBS (TBS-TX) for 15 min and blocked in 
1% BSA in TBS-TX for 20 min. Tight junctions were stained
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Table 3.1.  Real time PCR primers for mouse alpha and beta defensins. 
 
Gene Forward Reverse 
mAD-1 GTC GCT GAA CAT GGA GAC CA GAA GTG GTC ATC AGG CAC CA 
mAD-2 CTG CTC ACC AAT CCT CCC A GCC TGG ACC TGA AAG GAC AGT A 
mAD-3 GAG CAG CCA GGG GAA GAC ACC AGA TCT CTC AAC GAT TCC TCT 
mAD-4 TTC ATG AAA AAT CTT TGA GAG GTT TGT GCA GTA CAA AAA TCG TAT TCC ACA AGT 
mAD-5 GGA CCT GCA GAA ATC TTT TTT TAA CTT CTC AGA GCC GAT GGT TGT CA 
mBD-1 GAA CAC GGT ACA CAG GCT TCC CCT GAA TCA CAG ATG TCC AAG 
mBD-2 CTC TCT GGA GTC TGA GTG CCC AGG ACG CCT GGC AGA AGG AGG 
mBD-3 GAT TGG CAG TTG TGG AGT TCC GTC CAT CTT CAT GGA GGA GCA 
mBD-4 ACA TGC ATG ACC AAT GGA GCC CAT CTT GCT GGT TCT TCA TCT 
mBD-5 GCT GCT GTG TCC ACT TGC AA TGC CTC CAA TCA TAC AGC AAC T 
GAPDH ACT CCA CTC ACG GCA AAT TCA ACG G AGG GGC GGA GAT GAT GAC CC 
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with primary rabbit anti-ZO-1 (Invitrogen) followed by secondary antibody goat anti–
rabbit IgG conjugated to AlexaFluor 594 (Invitrogen). Samples were mounted with 
Prolong Gold antifade reagent containing DAPI.  Confocal images were taken with a 
Leica laser scanning confocal microscope using a 63!lens.  Contrast and brightness of 
individual channels were adjusted linearly in Adobe Photoshop CS5.  
 
Statistical Analysis 
Measurement of 48 crypt-villus units for quantitative morphological analyses provides 
a power of 0.8 to detect a difference of 0.414 standard deviations at a significance 
level of 0.05.  Statistical analyses were performed using GraphPad Prism Software (La 
Jolla, CA). Differences between groups were analyzed by unpaired t-test. Values for 
*p < 0.05 were considered significant. 
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Results 
T. gondii oral infection in mice induces an inflammatory response and 
morphologic changes in the small intestine 
Oral infection with T. gondii results in Th-1 type immunopathology in the small 
intestine of inbred C57BL/6 mice (33, 49).  Intestinal epithelial cells are important for 
responding to T. gondii oral infection and these responses involve TLRs (43, 50). Yet, 
little is known about how the intestinal environment changes during the early contact 
with the parasite and about early progression of the infection.   The intestinal 
epithelium integrity is maintained by the stem cells in the crypt which differentiate 
into different subtypes:  the absorptive enterocytes, mucus producing goblet cells, 
hormone producing enteroendocrine cells, and the antimicrobial peptide producing 
Paneth cells (2).  To characterize the effect of T. gondii infection and the morphologic 
changes in the intestinal epithelium, wild type C57BL/6 mice were orally infected 
with type II low virulence ME49 cysts. The mice were monitored for weight changes 
over time (Fig 3.1 A).  At day 7, the mice were sacrificed and the small intestine was 
collected for histological analysis.   In agreement with previous studies, wild type 
mice continuously lose weight beginning at day 3 post infection (Fig 3.1 A).  
Histological analyses of the terminal ileum showed severe ileitis in the infected wild 
type mice characterized by villus blunting, crypt abscesses and inflammatory infiltrate 
in the mucosa (Fig 3.1 B, C).  Additionally, quantification of ileal pathology showed a 
significant reduction in villus length, and in the number of both goblet cells and 
Paneth cells when compared to uninfected mice (Fig 3.1 D, E, and F).  Together, these 
results suggest that T. gondii infection changes the intestinal villus architecture as well 
as goblet cells and Paneth cell numbers.   
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Figure 3.1.   Oral infection with T. gondii alters numbers of goblet cells, Paneth 
cells, and villi length in the small intestine. WT (C57BL/6) mice were orally 
infected with T. gondii ME49 cysts.  After 7 days, small intestines were collected and 
subjected to histologic analyses with H&E, PAS, and Lendrum's staining.  Infected 
mice showed histopathological changes in the infected mice (C) when compared to the 
PBS control (B).  Staining and quantification showed shortened villi (D), decreased 
goblet cells (D) and Paneth cells (F) in T. gondii infected mice.    
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Oral infection with T. gondii induces chemoattractant cytokines  
The development of acute ileitis during T. gondii infection is characterized by over 
production of IFN-!, TNF-", and IL-12 and extensive immune cell infiltration to the 
gastric mucosa (33, 49).  Analysis of mRNA expression in the infected intestine tissue 
at day 7 confirmed that IFN-! and TNF-" were highly expressed following infection 
(Table 3.1, IFN- !, 34.1 fold; TNF- ", 5.5 fold).  It is notable that TLR4 and MyD88 
transcripts were also upregulated after infection, since these innate immune effects 
have been found highly expressed at the terminal ileum of ulcerative colitis and 
Crohn’s disease patients due to the accumulation of gram-negative bacteria (51-54).   
In addition to the Th-1 type proinflammatory genes, several chemokines such as 
CCL2, CCL7, and CXCL5, important for monocyte, T cell, and dendritic cell 
trafficking, were also highly upregulated during infection.   Therefore, these results 
suggest that the small intestine responds to T. gondii infection by upregulating 
chemoattractants for innate immune cell recruitment to the site of infection.     
 
T. gondii induces migration of dendritic cells to the FAE in a MyD88 dependent 
manner 
CD4+ and CD8+ T cell immune responses are required for the host to survive T. 
gondii infection, and activation of these cells depends on the encounter between 
antigen presenting cells and the parasite (34).  The Peyer’s patches are secondary 
lymphoid tissues in the small intestine and are the major inductive site for mucosal 
adaptive immunity.  
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Table 3.1.  A list of genes determined by Real-Time PCR induced by T. gondii in the 
small intestine at day 7 after oral infection.  Fold regulation greater than 3 are shown.    
 
Gene Genbank No. Fold Regulation 
Ccl2 NM_011333 111.0 
Ccl7 NM_013654 85.9 
Ifng NM_008337 34.1 
Cxcl5 NM_009141 13.6 
Tlr4 NM_021297 10.9 
Icam1 NM_010493 9.2 
Mmp3 NM_010809 7.9 
Cd34 NM_133654 7.3 
Il27 NM_145636 7.2 
Il10 NM_010548 6.7 
Tnf NM_013693 5.5 
Traf6 NM_009424 5.4 
Cd40lg NM_011616 5.3 
Cd4 NM_013488 5.3 
Cd8a NM_001081110 5.1 
Myd88 NM_010851 4.9 
Cxcl1 NM_008176 4.7 
Il12rb2 NM_008354 4.7 
Socs1 NM_009896 4.5 
Mmp13 NM_008607 3.7 
Il1b NM_008361 3.6 
Cd28 NM_007642 3.4 
Il21 NM_021782 3.1 
Il7r NM_008372 3.0 
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Dendritic cells (DCs) located in the subepithelial dome region of the Peyer’s patch are 
critical for initiating the mucosal T cell responses.  Previous studies have shown that 
TLRs regulate the follicle associated epithelium (FAE) to promote antigen capture by 
DCs (26).  TLR/MyD88 signaling is also critical for initiating defense against T. 
gondii infection (55-58).   To determine whether T. gondii have a TLR dependent 
effect on FAE function and DC migration, a surgical ligated intestinal loop containing 
a Peyer’s patch was injected with T. gondii tachyzoites in MyD88-/- or control wild 
type littermates.  Peyer’s patch tissue samples were collected after 90 minutes and 
analyzed for CD11c+ DCs in the FAE.  Results showed that during live T. gondii 
infection, the parasites induced migration of DCs into the FAE in wild type mice, but 
this was not observed in the MyD88-deficient mice (Fig 3.2 A and B).   These results 
suggest that T. gondii directly regulates FAE function and induces DC migration 
dependent on TLR signaling.   
 
Intestinal epithelial cells upregulate tight junction proteins and defensins in 
response to T. gondii infection. 
The intestinal epithelium is an important physical barrier for separating the commensal 
bacteria from the lamina propria, as well as for secreting antimicrobial peptides to 
maintain the homeostasis of the gut.  Intestinal epithelial cells express several TLRs 
including TLR2, TLR4, and TLR9 that are linked to initiating immune response 
during T. gondii oral infection (42, 59-61).  Stimulation of TLR2 in colonic epithelial 
cells are important for the biogenesis of tight junction proteins (17, 62). Secretion of 
!- defensin during T. gondii infection is dependent on TLR9 (43).   Here, we use the 
mouse intestinal epithelial cell line mICc12 to study the tight junction response and 
induction of defensins during T. gondii infection.  The mICc12 cells are a crypt-like 
murine small intestinal cell line that polarized within 6 days (44). The epithelial 
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Figure 3.2.  T. gondii induce the migration of dendritic cells (DCs) into the 
follicle-associated epithelium (FAE) in a MyD88-dependent manner.  (A) Model 
of Peyer’s patch structure (63).  (B) Frozen tissue sections stained with anti- CD11c+ 
(red) and DAPI (blue) showed increased DCs in the FAE after exposure to T. gondii 
tachyzoites.  Images shown are region corresponding to the illustration in (A). Dotted 
line defines the basal limit of the FAE as determined by staining for laminin.  
Representative images show that the migration of CD11c+ DCs (arrows) was induced 
upon exposure to T. gondii in MyD88 +/+ mice, but not in MyD88 deficient mice. (C) 
Quantitative analysis of DCs that have migrated to the FAE in control or T. gondii 
infected Peyer’s patch.  Data are from one experiment with one mouse for each 
treatment. 
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monolayer was infected with RH-YFP tachyzoites for 6 hours, which allows the 
parasites to invade into the host cells but not to complete a replication cycle, and then 
stained for the tight junction marker ZO-1.   Confocal microscopy images showed 
higher intensity in ZO-1 staining when cells were infected with T. gondii parasites 
(Fig 3.3 A).   This was also observed in polarized mICc12 monolayers treated with 
flagellin, but not with Pam3Cys or CpG treatment (Fig 3.3 A). The epithelial 
monolayer eventually looses the tight junction barrier after 24 hours of infection (Fig 
3.3 B); however, this might be due to multiple replication cycles of the parasites that 
causes the lost of barrier integrity.  
 
The crypt epithelial cells of the villus are know to secrete several antimicrobial 
peptides as a defense mechanism to pathogens (64).  To test what types of defensins 
were induced following T. gondii infection, total RNA from mICc12 cells was collected 
at 6 hours post infection and the expression level of alpha and beta defensins was 
analyzed by real-time PCR.   Results show that infection with T. gondii tachyzoites 
induced mouse !-defensin-3 (4.5 fold), as well as low levels of "-defensin-5 (1.9 fold) 
(Fig 3.4 A, B).  Taken together, these results suggest that T. gondii infection causes 
epithelial cells to enhance tight junctions and upregulate defensins within few hours of 
infection. 
 
T. gondii induced migration of dendritic cells to the FAE is dependent on TLR2 
We previously showed that intestinal epithelial cells respond to T. gondii directly via 
TLR2.   Therefore, we next asked whether DC migration in the Peyer’s patch depends 
on TLR2.  Surgical ligated loops in TLR2 deficient and control wild-type mice were 
either injected with control media or RH tachyzoites. After 90 minutes Peyer’s patches 
were collected, sectioned, and immunofluorescently stained for laminin and the DC  
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Figure 3.3. T. gondii infection of mouse small intestinal epithelial cells regulates 
tight junctions.   (A) Immunofluorscent staining of tight junction marker ZO-1 in 
mICc12 cell after infection with RH-YFP tachyzoites infection.  The intensity of ZO-1 
staining was increased 6 hours after parasite infection when compared to uninfected 
controls.  (B) mICc12 cell ZO-1 is disrupted after 24 hours post infection.  
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Figure 3.4. T. gondii infection of small intestinal epithelial cells induce mouse a-
defensins-3 and b-defensin-5 upregulation of mRNA transcripts.   Mouse alpha (A) 
and beta (B) defensin gene transcript levels was measured by Real-Time PCR analysis 
6 hours post T. gondii infection.   The data are normalized to GAPDH and compared 
against uninfected expression levels (REL, relative expression levels). 
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marker CD11c.  Although live T. gondii induce migration of DCs to the FAE in wild 
type mice, DC migration was not seen in the TLR2 deficient mice (Fig 3.5 A, B).  
Taken together, these results suggest that the migration of DCs to the FAE induced by 
T. gondii in the small intestinal Peyer’s patch is dependent on TLR2.    
  
Oral infections with T. gondii in TLR2 deficient mice is characterized by less gut 
pathology, and maintenance of Paneth cell numbers and granules 
Our study showed that DC migration is dependent on TLR2.  We next examined 
whether TLR2 influenced the outcome of parasite-induced pathology.  To further 
investigate the role of TLR2 during infection, we orally infected wild type and TLR2 
deficient mice with ME49 cysts to and monitored weight loss over time.  TLR2 
deficient mice were resistant to T. gondii induced weight loss when compared to wild 
type infected mice  (Fig 3.6 A).   Histological analyses of the terminal ileum showed 
reduced length of villi, reduced Goblet cell numbers and a dramatic reduction in 
Paneth cell nembers in infected wild type mice.  However, in TLR2 deficient mice 
there was no reduction in villus length, and a much less dramatic reduction in Goblet 
and Paneth cell numbers (Fig 3.6 D, E, F).   Closer examination of the ileal crypts in 
the uninfected TLR2 knockout mice demonstrated that, in the absence of infection, 
they have fewer Paneth cell numbers when compared to wild type mice (Fig 3.6 F). 
(Fig 3.5 D, E, and F).  Taken together, our results demonstrate that TLR2 plays a role 
in developing T. gondii-induced intestinal pathology by modulating effector cell 
numbers and function. 
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Figure 3.5.  T. gondii induced migration of dendritic cells (DCs) into the follicle-
associated epithelium (FAE) is dependent on TLR2.  (A) Peyer’s patch from wild 
type or TLR2 deficient mice were collected after 90 minutes of intraluminel injection 
of control (media) or live T. gondii parasites.  Frozen tissue sections were stained with 
anti- CD11c+ (red), DAPI (blue). The dotted line defines the basal limit of the FAE as 
determined by laminin staining.  Representative images show that the migration of 
CD11c+ DCs (arrows) was induced upon exposure to T. gondii in wild type mice, but 
not in TLR2 deficient mice. (B) Quantitative analysis of DC that has migrated to the 
FAE in control or T. gondii infected Peyer’s patch.  
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Figure 3.6.  TLR2 deficient mice are more resistant to T. gondii induced 
pathology.  Wild type (C57BL/6) and TLR2 deficient mice were orally infected with 
20 ME49 cysts.  (A) Following oral infection, TLR2 deficient mice showed less 
weight loss compared with wild type controls.  (B, C)  Small intestines were isolated 
at day 9 and subjected to PAS for goblet cell identification and Lendrum’s stain for 
and Paneth cells.  TLR2 deficient mice showed less histopathological changes, as well 
as less decrease in goblet cells and Paneth cells.  Representative images of the crypt 
Paneth cells were shown.   (D, E, and F) Quantification of villi length, goblet cell, and 
Paneth cell numbers.  
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Discussion 
The intestinal epithelium is a strategic place to respond to pathogenic invasion as well 
as orchestrate signaling cascades for host protection and control inflammation.  In our 
previous study we demonstrated that TLR2 involved in activating inflammatory 
responses during T. gondii infection.  Here, we demonstrate that TLR2 modulates the 
intestinal epithelial function during T. gondii infection, which leads to changes in the 
intestinal microenvironment.  
 
The present work demonstrates that oral infection of susceptible mice C57BL/6 mice 
with low virulence ME49 cysts results in intestinal inflammation, reduced goblet cells, 
Paneth cells, and discharge of granules into the crypt lumen.  The T. gondii-induced 
pathology in theses mice is similar to inflammatory bowel disease (IBD) in human (33, 
65).  Crohn’s disease and ulcerative colitis are the two main groups of IBD.  In the 
healthy intestine, secretion of protective factors such as mucins and antibacterial 
peptides in the epithelium can effectively control the commensal load in the intestine 
to avoid inflammation (66, 67).  Human IBD is often characterized by heavy loads of 
bacteria in the mucus that adheres or invades the intestinal epithelial cells, which leads 
to breakdown of the epithelial barrier function (68).  The reduction of goblet cells in 
mice infected with T. gondii observed in this study is similar to what is observed in 
ulcerative colitis patients (69). The depletion of goblet cells results in a thinner mucus 
layer can increase the epithelial cell-bacteria contact and therefore exacerbate the 
inflammatory response in the small intestine.  Paneth cells contain granules that 
secrete antimicrobial peptides to maintain homeostasis of the intestine.  We show that 
oral infection results in decrease of Paneth cell numbers after T. gondii infection.  In 
previous studies, T. gondii infection induces microflora changes and accumulation of 
gram-negative bacteria at the inflamed sites of the intestine (37, 70).  It is possible that 
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the reduction of Paneth cell numbers during T. gondii infection results in decreased 
defensin production and alters the luminal bacterial composition.    
 
Acute ileitis induced by T. gondii may involve multiple TLR and multiple epithelial 
cell types.  In the case of TLR2 deficient mice, they are more resistant to T. gondii-
indued pathology as demonstrated by a milder reduction in goblet cell, Paneth cell, 
and less discharge of granules into the lumen of the small intestine crypt.  This result 
is similar to other oral infection studies done in transgenic mice lacking bacterial 
sensing TLRs (TLR2!4 and TLR9) or chemokine receptors (CCR2), where less 
intestinal inflammation and IL-12 production was observed (39, 40).   The emerging 
proposed model is that immunopathology induced by T. gondii infection is caused by 
immune reaction against the luminal bacteria rather than the parasite itself.   
Interestingly, we observed a lower number of Paneth cells, as well as fewer granules 
discharge into the crypt lumen in TLR2 deficient mice. Similar reduction of Paneth 
cells is also observed in MyD88 deficient mice (Rose and Leifer, unpublished 
observations).  It is not clear whether reduced Paneth cell numbers result in 
differences of gut microbiota content in the TLR2 or MyD88 deficient mice. However, 
it is possible that proper TLR signaling through the commensal bacteria in the small 
intestine is required for the differentiation and function of Paneth cells.   
TLR2 may play multiple and opposite roles in regulating the intestine at different 
times following infection. The TLR2 agonist synthetic Pam3Cys-SK4 (PCSK) 
enhances ZO-1 junctions in human colonic intestinal cell lines and ameliorate damage 
to the epithelial barrier in DSS colitis models (17, 62, 71).   In our study using the 
murine small intestinal cell line mICc12, direct stimulation with bacterial flagellin or 
live tachyzoites for 6 hours also enhanced tight junction in the epithelial cells.  The 
effect of T. gondii infection was more dramatic than that observed with TLR2 or 
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TLR9 ligands.   Since live infection was more dramatic than direct TLR2 stimulation, 
it is likely that invasion of parasites into the cells activates other intracellular pathways 
that upregulates ZO-1 independent of TLRs.  However, ZO-1 tight junctions are 
eventually disrupted after several replication cycles in the intestinal epithelial cells, 
suggesting that higher permeability through the epithelial barrier may facilitate 
bacterial leakage into the lamina propria.    
 
Defensins are cationic anti-microbial peptides that are important effectors in intestinal 
innate immunity.   Foureau and colleagues have demonstrated that T. gondii induces 
!-defensin production and release by Paneth cells via a TLR9-dependent induction of 
type I IFNs (43).   In our study, we show that early and direct contact of T. gondii with 
crypt–like small intestinal epithelial cells induced rapid induction of a-defensin-3 and 
"-defensin-5.  Defensins are able to kill other protozoan parasites such as Giardia 
lamblia (72), but whether they play a direct role in eliminating T. gondii is not known. 
!-defensins have biological effects in epithelial cells that enhance mucosal protection 
in addition their antimicrobial activities. !-defensin-3 forms pores in the apical 
membrane of intestinal epithelial cells and lead to chloride secretory response.   Such 
response would lead to salt and water secretion in epithelial cells, and flush the 
bacteria off the epithelial surface (73).  Another study also reported that ! -defensin-3 
induces secretion of the neutrophil chemoattractant IL-8 through Ca2+-dependent 
activation of the p38 and NF-!B signaling (74).  
 
The Peyer's patch is the primary site for induction of mucosal immune responses. 
Dendritic cells in the Peyer’s patch are known to have the ability to prime T cells and 
help IgA B cell differentiation, as well as uptake antigens transcytosed from the FAE 
and activate T and B cell in the interfollicular regions (75, 76).  Movement of DCs 
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beneath the FAE into the intraepithelial layer promotes rapid capture of antigens and 
microorganisms. In the current study, we showed that T. gondii tachyzoites promote 
the migration of DCs to the FAE within 90 minutes in a TLR2 dependent manner.  T. 
gondii possesses TLR2 (GPIs) and TLR11 (profilin) ligands (60, 77).   However, more 
recent studies have shown that TLR11 is expressed intracellularly (observations by F. 
Yarovinsky).  Therefore, it is possible that DC migration during T. gondii infection 
depends on TLR2 expressed on the surface of FAE, but the production of IL-12 from 
DCs is dependent on TLR11 or bacteria sensing TLRs (TLR2, TLR4, and TLR9) in 
order to initiate Th1-polarizing response.   
 
Several studies have reported the cross talk of epithelial cells and dendritic cells in the 
intestine.  In the lamina propria, villous epithelial cell TLR signaling upon exposure to 
microbial stimuli induces DC sampling of the lumen (78-80).  In the Peyer’s patch, a 
subset of DCs also responds to FAE secreted cytokines and sample antigens 
transported by M cells (81).  However, there are several subsets of Peyer’s patch DCs, 
which are distinguished based on their surface markers and functional activity.  
CD11b+ CD8a- CCR6+ DC primarily mount a Th2 responses, whereas CD11b- CD8a+ 
CCR6- and CD11b- CD8a- CCR6+ DC activate Th1 responses (82).  In this study, it is 
not clear whether the FAE upregulates chemokine mRNA and protein synthesis, or 
secretes other chemotactic molecules, to induce DC migration within 90 minutes. An 
alternative possibility is that T. gondii antigens cross the FAE and directly induce the 
DC movement within the Peyer’s patch.  Regardless of the exact mechanism, our data 
demonstrate that the innate response to T. gondii enhances DC migration in the 
Peyer’s patch in a TLR2 dependent manner and that this response may promote 
adaptive immune responses in the intestinal mucosa.  Further studies are required to 
identify the subset of DCs in the Peyer’s patch that are recruited to the FAE, whether 
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they initiate a Th1 response during T. gondii infection, and whether the effect on these 
cells is direct, or via T. gondii activation of the FAE. 
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Abstract 
Toxoplasma gondii is an obligate intracellular parasite that has multiple surface 
antigens as well as cytoplasmic proteins that can initiate host inflammatory responses.   
In this study, we show that supernatants collected from T. gondii infected cells were 
capable of activating immune responses in intestinal epithelial cells. Similar to live 
parasite infections, the supernatant from infected cells contains parasite-derived 
mediators that trigger NF-!B activity through TLR2.  Glycosylphosphatidylinositols 
(GPIs) isolated from T. gondii were previously demonstrated to activate TLR2 and 
TLR4.   Therefore, we used nano-LC-MS/MS to identify T. gondii GPI anchored 
proteins in supernatants, and found two candidate proteins: surface antigen 1 (SAG1) 
and subtilisin-like protein (TgSUB1). The TLR2 stimulatory activity was reduced in 
supernatants from SAG1 deficient parasites, but not the TgSUB1 deficient parasites.  
T. gondii SAG1 were previously shown to be involved in inducing ileitis in 
susceptible C57BL/6 mice. Therefore we tested whether the supernatants from T. 
gondii infected cells, which contains SAG1, promote capture of incoming antigens by 
dendritic cells in the Peyer’s patch.  Using a surgical ligated loop model, we show that 
the supernatant from T. gondii infected cells enhances the transepithelial transport of 
fluorescent microbeads and induces dendritic cell migration to the follicle-associated 
epithelium. Furthermore, dendritic cell migration induced by supernatant from 
infected cells was dependent on TLR2. 
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Introduction 
The obligate intracellular parasite Toxoplasma gondii is a widespread protozoan 
parasite that belongs to the phylum Apicomplexa that infects a variety of nucleated 
mammalian and avian cell types (1).  Individuals are infected with the parasite by 
ingesting contaminated food or water from oocysts or tissue cysts containing 
bradyzoites.   Once in the small intestine, the bradyzoites convert to rapidly 
multiplying tachyzoites and invade target cells in the gut (2).  In most cases, with the 
exception of a certain inbred strain of mice, T. gondii does not cause a CD4+ T cell 
mediated immunopathology during the acute phase of infection (3, 4).   
 
In order to induce cell-mediated protective immunity against T. gondii in intermediate 
hosts, numerous studies on T. gondii vaccine designs were based on attenuated 
parasite or DNA vaccines encoding proteins from parasite secretory organelles such as 
dense granule proteins GRA-1, -2, -4, -6, -7, rhoptry proteins ROP-1, -2, and 
microneme proteins MIC-1, -2, -3, -4 (5-12).  Other T. gondii derived antigen 
molecules including heat shock protein-70, -30 (13-15), M2AP (MIC2-associated 
protein), AMA1 (apical membrane antigen-1) and SAG-1, -2 (surface antigen-1, -2) 
are also strong inducers of immunity (10, 16).   However, protective immune 
responses triggered by these antigens varies, and little is known about whether these 
antigens play a role in initiating response at the mucosal surface during infection.   
 
During the acute phase of T. gondii infection, intestinal epithelial cells can initiate 
series of immunologic events that leads to a robust inflammatory response in the gut.   
Studies have shown that these responses involve Toll-like receptors (TLRs).  In 
MyD88 deficient mice, oral infection with T. gondii demonstrates a defect in 
neutrophil recruitment to the site of infection, early IFN-! production by T cells, and 
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induction of p47 GTPase IGTP (Irgm3). (17).   This suggests that early TLR signaling 
at the mucosal surface during oral infection is important for triggering protective 
responses.  T. gondii  possesses several TLR ligands including profilin and cell surface 
GPI anchors that activate TLR11, and TLR2 and TLR4 respectively (18, 19).   One of 
the T. gondii-derived antigens that induces strong immunopathology at the ileum is the 
GPI-anchored protein SAG1 (20).   SAG1 is exclusively expressed on the surface of 
tachyzoites and can induce dominant antibody responses, and high IFN-! production 
by T lymphocytes (21, 22).  Our previous study demonstrated that intestinal epithelial 
cell response to T. gondii infection relies on TLR2 signaling, and oral infection of T. 
gondii in TLR2 deficient mice develop less pathology (Chapter 3).  TLR2 is expressed 
in the follicle-associated epithelium covering lymphoid follicles of the mucosa-
associated lymphoid tissues (MALT) of Peyer’s patches in mice (23).  The function of 
the follicle associated epithelium is distinct from other types of mucosal epithelial 
cells because the follicle associated epithelium contains M cells that transport and 
deliver luminal antigens into MALT, where adaptive mucosal immune responses are 
initiated.   In our study, we show that T. gondii–derived factors in the supernatants 
elicit inflammatory response similar to live parasite infection.  This response is 
dependent on the parasite GPI-anchored protein SAG1.  Similar to live parasite 
infection, supernatant from T. gondii infected cells enhance the transport of luminal 
antigens, and induce a TLR2 dependent dendritic cell migration to the follicle 
associated epithelium. 
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Materials and Methods 
Experimental Animals 
MyD88+/+ and MyD88–/– mice originally generated by S. Akira (Osaka University, 
Osaka, Japan) and provided by Dr. Eric Denkers (Cornell University, Ithaca, NY) were 
generated by crosses of heterozygous mice.  TLR2 -/- (Tlr2tm1Kir) with a C57BL/6 
background and wild type (C57BL/6) mice were obtained from The Jackson 
Laboratory (Bar Harbor, ME).  TLR11-/- and TLR2!11-/- mice were provided by Dr. 
Felix Yarovinsky (University of Texas Southwestern Medical Center, Dallas, TX).  
All mice were used at 8-12 weeks of age.  The mice were bred and housed under 
specific pathogen-free conditions at the Transgenic Mouse Facility, Cornell University 
College of Veterinary Medicine, overseen by the Institutional Animal Care and Use 
Committee.  
 
Cell culture, parasite, and supernatant preparation 
Henle 407 (human embryonic intestinal epithelial cells), HEK293 (human embryonic 
kidney cells), and HS27 (human foreskin fibroblast) were maintained in Dulbecco’s 
modified Eagle’s medium (DMEM) supplemented with 2 mM L-glutamine, 50 
units/ml penicillin, 50 µg/ml streptomycin, 10 mM HEPES, 1 mM sodium pyruvate, 
and 10% low endotoxin fetal bovine serum.  T. gondii tachyzoites strain were 
maintained by serial 2 day passage on HS27 monolayers in DMEM.  Wild-type RH! 
(24), !sag1 (sag1 deficient parasite), and the sag1-complemented M34 tachyzoites 
were provided by Dr. Michael Grigg (NIH, MD).  Tachyzoites lacking subtilisin 
(DSUB1) that are complemented with control vector or the full-length TgSUB1 were 
provided by Dr. Kami Kim (25) (Albert Einstein College of Medicine, NY).   All cell 
cultures and parasites were tested negative for mycoplasma by a high sensitivity PCR-
ELISA based Mycoplasma detection kit (Roche, Indianapolis IN). Supernatants from 
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T. gondii infected cells were prepared by in vitro infections of T. gondii tachyzoites to 
HS27 fibroblasts or Henle 407 cells (MOI 30:1) for 20-24 h, supernatants were 
collected and passed through a 0.22 µm pore size filter.  Control supernatants were 
collected from non-infected cells.  Supernatants from Listeria monocytogenes and 
mock infection control supernatant were prepared by Dr. Hélène Marquis (Cornell 
University, Ithaca, NY).   
 
NF-!B translocation assay 
For immunofluorescence analyses, Henle 407 cells were plated at 2-3 ! 105 cells per 
well on sterile coverslips placed in wells of a 24-well plate.   Cell monolayers were 
infected with T. gondii RH-YFP tachyzoites and were then fixed with 3% 
paraformaldehyde in PBS for 20 min at room temperature.  Fixed cells were 
permeabilized with 0.1% Triton X-100 in TBS (TBS-TX) and blocked in 1% BSA in 
TBS-TX.  The cells were then stained with primary rabbit anti-NF-"B p65 followed 
by secondary antibody goat anti–rabbit IgG conjugated to AlexaFluor 594.  Nuclei 
were stained using DAPI.   Confocal images were taken with a Leica SP5 laser 
scanning confocal microscope.  For immunoblot analyses, Henle 407 cells were plated 
at a number of 1.5 ! 106 cells per well in 6-well plate and stimulated with T. gondii 
infected supernatants for the indicated times.  Cytoplasmic and nuclear proteins were 
isolated according to previous protocols (26) and blotted for NF-"B p65.   
RNA extraction and PCR analysis  
Total RNA was extracted using the RNeasy mini kit (QIAGEN, Valencia, CA).   
Reverse transcription of the RNA (1 µg) was performed using SuperScript III Reverse 
Transcriptase Kit with the supplied Olige-dT primers (Invitrogen, Carlsbad, CA). 
Real-time PCR was performed on the Applied Biosystems 7500 Fast Real-Time PCR 
System (Applied Biosystems, Foster City, CA) with the SYBR green detection reagent 
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(40 cycles at 95°C for 10 s and at 60°C for 1 min).  Glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) was used as an internal control for each sample.  Percentage 
of relative expression level (REL%) was calculated using the 2!""Ct method.  Primers 
for IL-8 and GAPDH were used as described in chapter 2.  
 
In vitro infections 
T. gondii tachyzoites or supernatants from infected cells were added to Henle 407 cells 
and were briefly centrifuged (400 # g, 1 min) to initiate parasite and cell contact.  At 
time points indicated in each figure legends, cell lysates were collected and 
immunoblotted for total and phosphorylated forms of ERK1/2, and p38, (Cell 
Signaling Technology, Danvers, MA).   !
!
Luciferase reporter assays 
HEK293 cells were plated at 1 x 104 cells/well in 96-well plates.  Cells were 
transfected using TransIT Transfection Reagent (Mirus) and a total of 200 ng 
DNA/well consisting of different TLR plasmids, and a NF-!B luciferase reporter.  
Cells were stimulated with TLR ligands, or infected with T. gondii tachyzoites, lysed 
in reporter lysis buffer (Promega), and assayed for luciferase (Promega) activity.  NF-
!B activity was calculated and processed by Graphpad Prism Software.   
!
Surgical ligated intestinal loops 
Mice were anesthetized by intraperitoneal (i.p.) injection of avertin (tribromoethanol in 
t-amyl alcohol; 150 mg/kg animal weight), and a 3- to 5-cm segment of ileum 
containing a PP was ligated and injected as protocols described previously (27).  
Loops were injected with approximately 200 ml of sample supernatants. For 
measuring follicle associated epithelium transport of microparticles, sample 
 129!
supernatants were injected in combination with fluoresbrite plain yellow-green 0.2-µm 
microbeads (Polyscience, Werrington, PA).  After 60 (for microbeads) or 90 (for DC 
migration) minutes, animals were sacrificed, and PP were excised, washed in cold 
PBS, immediately embedded in Tissue-Tek OCT-embedding medium (Sakura, 
Torrance, CA), frozen in 2-methylbutane (Sigma-Aldrich, St. Louis, MO) cooled with 
liquid nitrogen, and stored at –80°C until sectioned.  
 
Immunohistochemistry 
Immunohistochemistry was performed on fresh frozen Peyer's patch (PP) tissue 
sections.  Cryosections (3-5 µm) of frozen PP were cut on a cryostat model MICROM 
HM 525, mounted on Superfrost Plus microscope slides, air-dried overnight, and fixed 
with cold acetone for 2 minutes.  Cryosections were blocked using PBS containing 2% 
goat serum. The following primary antibodies were used: biotin-conjugated rat anti-
mouse CD11c (BD Pharmingen, San Diego, CA), and rabbit anti-mouse laminin (MP 
Biomedicals, Solon, OH).  As secondary reagents, the following were used:  
streptavidin-Alexa-488 or -647 (Molecular Probes) for CD11c detection, and goat 
anti-rabbit-Alexa-488 or 647 (Molecular Probes, Carlsbad, CA) for laminin detection.  
All stained tissues were mounted with Prolong Gold antifade reagent containing DAPI 
(Invitrogen, Carlsbad, CA). 
 
Microscopy and image analysis 
Fluorescence images were collected on an AxioImager M1 microscope (Carl Zeiss 
MicroImaging, Inc.) using a 20! objective (200! magnification). AxioVision Rel. 4.8 
software was used for image capture and processing.  Brightness and contrast was 
adjusted using Adobe Photoshop CS5 software, and changes were applied equally 
across the entire images. 
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Analysis of DC migration and statistics 
The numbers of intraepithelial CD11c+ DCs within the follicle associated epithelium 
were quantified by the following method:  Peyer's patches from each mouse were 
sectioned, and four non-contiguous sections from the central region of each Peyer's 
patch that included the apex of one or more follicle domes were selected.  The laminin 
staining was used as reference for drawing dotted lines to represent the basal limit of 
the epithelium.   All CD11c+ cells located within the follicle associated epithelium as 
well as cells that associated with the basal limit of the epithelium were counted.  Data 
were expressed as mean DCs per follicle associated epithelium sample.   Thus, data 
from each treatment group represented the average of at least 4 separated segments of 
follicle associated epithelium.  Statistical analyses were performed using GraphPad 
Prism Software (La Jolla, CA).  The difference between control and T. gondii-infected 
supernatant were analyzed using an unpaired t test.  Differences with *p < 0.05, were 
considered statistically significant. 
 
Protein identification by nano LC-MS/MS 
Supernatants from infected cells were collected as described above and concentrated 
by a 30, 000 Da MWCO centricon.   The supernatant proteins were separated by 10% 
SDS-PAGE and visualized by Coomassie Blue stain.  The protein analysis of the 1D 
gel sample was performed at The Proteomics and Mass Spectrometry Core Facility, 
Institute for Biotechnology and Life Sciences (Cornell University, Ithaca, NY).  The 
MS/MS data generated were submitted to Mascot 2.2 for database searching using 
Mascot local server and the search was performed to query to NCBInr (Taxonomy: 
Eucaryota) database (downloaded on July 28th, 2008 with 2,073,350 entries after 
taxonomy filter) with one missed cleavage site by trypsin allowed.  The peptide 
tolerance was set to 1.5 Da and MS/MS tolerance was set to 0.6 Da.  
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Carbobamidomethyl modification of cysteine and a methionine oxidation were set as 
variable modifications. Only significant scores for the peptides defined by Mascot 
probability analysis greater than “identity” with 95% confidence interval were 
considered for the protein identifications.  
 
Results 
T. gondii induced nuclear translocation of NF-!B is not restricted to infected cells 
In our previous study, we showed that T. gondii induced NF-!B nuclear translocation 
in epithelial cells infected with tachyzoites (28).  However, this is not restricted to 
infected cells, but also in adjacent non-infected cells (Fig 4.1 A).  Soluble factors in 
the supernatant may be capable of inducing NF-!B translocation to the nucleus.   To 
test this, we collected supernatants from cells that were infected with live tachyzoites. 
The supernatant was filtered to exclude live parasites (Fig 4.1 B) and then applied to 
Henle 407 cells, a human small intestinal epithelial cell line.  At the indicated time 
points, cytoplasmic and nuclear proteins were collected and blotted for p65 NF-!B.   
Results show that without live infection, the supernatants collected from T. gondii 
infected cells are capable of activating NF-!B nuclear translocation (Fig 4.1 C). 
 
Supernatants from T. gondii infected cells induce inflammatory responses similar 
to live infection 
To test whether supernatants collected from T. gondii infected cells elicited 
inflammatory responses similar to live infection in epithelial cells, we examined 
MAPK activation and IL-8 mRNA induction by Henle 407 cells stimulated with 
supernatants from infected cells.  Similar to live parasite infection, intestinal epithelial 
cells responded to supernatants collected from T. gondii infected cells by 
phosphorylating ERK and p38 MAPKs as early as 15 minutes (Fig 4.2 A) and 
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upregulated IL-8 mRNA transcripts at 4 h post infection (Fig 4.2 B).   Taken together, 
these data demonstrate that supernatants collected from T. gondii infected cells elicited 
inflammatory response with kinetics similar to live parasite infection. 
 
Supernatants from T. gondii infected cells activate TLR2 
We have previously shown that TLR2 is involved in epithelial recognition of T. gondii 
(28).  Therefore, we next ask whether supernatants from T. gondii infected cells 
contain soluble factors that activate TLRs.  HEK293 cells were transfected with 
different TLRs and an NF-!B luciferase reporter. While each positive control ligand 
stimulated NF-!B activation in the respective TLR expressing cells, supernatants from 
T. gondii infected cells activated NF-!B only in TLR2 transfected cells (Fig. 4.3).  To 
determine whether the TLR2 stimulatory activity derived from either the parasite, or 
secretory proteins from epithelial cells, we incubated T. gondii tachyzoites with Henle 
407 cells or media alone for 4 hours.  Supernatants were collected and tested for TLR2 
activity by luciferase reporter assay.   Results show TLR2 activity in supernatants 
from T. gondii with or without Henle 407 cells (Fig 4.4). Furthermore, the activity of 
supernatants from T. gondii infected cells was not genotype dependent (Fig 4.5).  
Importantly, supernatants from cells infected with Listeria monocytogenes did not 
activate TLR2.  Taken together, these data demonstrate that T. gondii infected 
supernatants contain T. gondii-derived soluble mediators that activate TLR2 (Fig 4.5). 
 
Supernatants from T. gondii infected cells contain several parasite and host 
derived molecules 
We next characterized the T. gondii infected supernatant.  To estimate the size of the 
molecule contained in the supernatant with stimulatory activity, the supernatants were 
filtered through a 30kDa molecular weight cut off (MWCO) centricon filter.  The  
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Figure 4.1.  T. gondii induced nuclear translocation of NF-!B was not restricted 
to infected cells.  (A) Henle 407 cells were infected with RH-YFP parasites for 2 
hours. NF-!B p65 localization was visualized by immunofluorescence staining with 
anti–NF-!B p65 (red). In uninfected cells, p65 was present in the cytoplasm, 
incubation with parasites for 2 hours resulted in nuclear localization of p65 in both 
infected and non-infected cells.  (B) Schematic procedure for collecting supernatants 
from T. gondii infected cells.  (C) Supernatants from infected cells were added to 
Henle 407 cells for the indicated times.  Cells were separated into cytoplasmic and 
nuclear fractions and analyzed for p65 by immunoblot.  
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Figure 4.2.   Supernatants from T. gondii infected cells induce an inflammatory 
response.  (A) Activation of MAPK in intestinal epithelial cells by supernatants from 
infected cells or live parasites.  Henle 407 cells were incubated with supernatants from 
RH infected cells or directly with RH tachyzoites for the indicated times. Whole cell 
lysates were collected for immunoblot analysis of total and phosphorylated forms of 
ERK/1/2 and p38 MAPK.  (B) Human IL-8 gene transcript levels were measured by 
real-time qPCR analysis 4 hours post stimulation. The data are normalized to GAPDH 
and compared against uninfected expression levels (REL, relative expression levels).   
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Figure 4.3.  Supernatants from T. gondii infected cells activate TLR2.   HEK293 
cells were transfected with different human TLRs and an NF-!B luciferase reporter 
plasmid.   The transfected HEK293 cells were stimulated with respective TLR ligands 
as positive controls or supernatants from infected cells.   Cell lysates were collected 
and assayed for luciferase activity (Triplicate assays, error bar = SD).   
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Figure 4.4. TLR2 activity in supernatants is parasite derived.  T. gondii 
tachyzoites were either incubated with host cells or media alone.    After 4 hours of 
incubation, supernatants were collected and added on to HEK 293 cells transfected 
with TLR2 and NF-!B luciferase reporter plasmids.   HEK 293 cells lysates were 
assayed for luciferase activity (triplicate assays; error bar, SD).   
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Figure 4.5.  Supernatants from cells infected with different genotypes of T. gondii, 
but not Listeria monocytogenes, activate TLR2.  HEK 293 cells transfected with 
TLR2 and NF-!B reporter plasmids were stimulated with supernatants collected from 
Henle 407 cells infected with different T. gondii strains.   L. monocytogenes and mock 
infection control supernatants do not have TLR2 stimulating activity (triplicate assays; 
error bar, SD).  
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activity of the supernatant was 30kDa or greater (Fig 4.6 A).  The supernatant (10 mg 
of total protein) was then separated by SDS-PAGE and visualized by Coomassie blue 
staining (Fig 4.6 B).  Six protein sections from the 1-dimensional gel were excised and 
subjected to nano LC-MS/MS analysis as described in the material and methods. The 
proteomic analysis revealed 10 T. gondii proteins and 26 Homo sapiens proteins 
present in the supernatants from T. gondii infected cells (Table 4.1 and Table 4.2).  
Several identified proteins were from T. gondii apical secretory organelles involved in 
host cell invasion; for example, MIC-2 from micromemes and GRA-3, -5, -7, -8 
proteins from dense granules.  The surface antigen 1 (SAG1) and subtilisin-like 
protein (TgSUB1) are important for host cell attachment and proteolytic processing 
during invasion, respectively, and were also detected in the supernatant.   Previous 
studies done by Debierre-Grocckeigo and colleagues showed that 
glycosylphosphatidylinositol (GPIs) purified from T. gondii tachyzoites are dependent 
on TLR2 and TLR4 for proinflammatory cytokines production in macrophages (18, 
29).  In this study, we have also shown that live T. gondii or infected supernatants 
trigger inflammatory responses through TLR2 in intestinal epithelial cells.  Therefore, 
we suspected the T. gondii related mediator, which signals through TLR2, was a GPI- 
anchored protein.   Of the T. gondii proteins identified by nano LC-MS/MS analysis, 
SAG1 and TgSUB1 were GPI-anchored proteins (30, 31). Since the cells used for 
culturing T. gondii were human foreskin fibroblasts, it was possible that T. gondii 
induced inflammatory cytokine secretion by these cells.  Of the proteins identified 
from human origin, none of the proteins were known to activate TLRs; however, 
human TNF-! was detected.  TNF-! is an inflammatory cytokine that activates the 
NF-"B signaling pathway through the TNF receptor.  Indeed, were able to detect very 
slight levels of TLR2 independent activity through the NF-"B luciferase reporter assay 
in the supernatant collected from infected cells.  Therefore, our data demonstrated that  
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Figure 4.6.  The TLR2 stimulating activity in supernatants from infected cells is 
greater than 30 kDa. (A) Supernatants from T. gondii infected or uninfected cells 
were filtered through molecular weight cut off centricons and tested for TLR2 
dependent NF-!B activity using the luciferase reporter system.  The TLR2 activity is 
in the concentrated fraction greater than 30 kDa.  Small amounts of proteins smaller 
than 30 kDa may be present in the concentrated supernatant.  (B) Supernatants from T. 
gondii infected cells containing 10 mg of total protein was separated by 1D SDS-
PAGE.   Proteins on the gel were visualized by Coomassie blue stain.  Six sections 
were excised for nano-LC-MS/MS analysis and were referred to as band 1a, 1b, 2, 3, 4, 
and 5.  Between band 3 and 4 was not collected due to the high amount of bovine 
serum at this molecular weight. 
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Table 4.1.  A list of T. gondii proteins identified by nano LC-MS/MS from supernatants collected from 
infected cells.  
 
Accession No. Protein Description Protein mass (Da) Peptide Sequence 
gi|161913 28kd antigen 28,018 VAEQLFR 
gi|1703160 Actin 41,881 CDVDIR 
gi|2507039 Dense granule protein 5 precursor GRA 5 12,969 TAVGLAAAVVAVVSLLR 
gi|22652337 Dense granule protein GRA3 24,227 RQPFMSSVK 
gi|2062409 Dense granule protein GRA7 25,347 ASVESQLPR 
gi|5901701 Dense granule protein GRA8 28,509 IPYGGAAPPR 
gi|133990372 Membrane skeleton protein IMC2A 168,163 VPPPEAEGR 
gi|1923217 Micronemal protein MIC2 82,567 TRYNDPPPQGAGR 
gi|15419013 Subtilisin-like protein 85,034 TPPSAPSPSPR 
gi|123186979 Surface antigen 1 32,519 LTVPIEK 
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Table 4.2.  A list of Homo sapien proteins identified by nano LC-MS/MS from supernatants collected from 
infected cells. 
 
Accession No. Protein Description Protein mass (Da) Peptide Sequence 
gi|4502049 aldo-keto reductase family 1, member B1 35,830 TTAQVLIR 
gi|4757756 annexin A2 isoform 2  38,580 TPAQYDASELK 
gi|230867 Chain R, Twinning In Crystals Of Human Skeletal Muscle D- Glyceraldehyde-3-Phosphate Dehydrogenase 35,853 VGVDGFGR 
gi|1199487 collagen binding protein 2  46,506 KPAAAAAPGTAEK 
gi|87196339 collagen, type VI, alpha 1 precursor 108,462 IALVITDGR 
gi|4503571 enolase 1  47,139 YNQLLR 
gi|31397 fibronectin precursor 256,529 ISCTIANR 
gi|53791219 filamin A 277,332 AGVAPLQVK 
gi|119593150 filamin A, alpha (actin binding protein 280), isoform CRA_a  248,350 VNVGAGSHPNK 
gi|5901956 follistatin-like 1 precursor  34,963 GAQTQTEEEMTR 
gi|4504165 gelsolin isoform a precursor 85,644 RTPITVVK 
gi|285975 human rab GDI 50,632 VPSTEAEALASSLMGLFEK 
gi|642534 lumican 38,375 ILGPLSYSK 
gi|4505763 phosphoglycerate kinase 1 44,586 YAEAVTR 
gi|189778 pigment epithelial-differentiating factor 46,300 ELLDTVTAPQK 
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Table 4.2.  (Continue) 
 
Accession No. Protein Description Protein mass (Da) Peptide Sequence 
gi|189578 plasminogen activator inhibitor 1 45,045 TPFPDSSTHR 
gi|35825 pregnancy zone protein 163,733 ATVLNYLPK 
gi|1418930 prepro-alpha2(I) collagen 129,258 GVVGPQGAR 
gi|642908 procollagen C-proteinase enhancer protein 47,916 VFDLELHPACR 
gi|17028367 Similar to gelsolin (amyloidosis, Finnish type) 30,995 YIETDPANR 
gi|180665 skin collagenase precursor 54,058 ADVDHAIEK 
gi|40317626 thrombospondin 1 precursor 129,300 GPDPSSPAFR 
gi|339992 tumor necrosis factor 41,975 LTSALDELLQATR 
gi|30102 type I collagen 41,496 AQPENIPAK 
gi|28872 unnamed protein product 46,397 EFVEEFIWPAIQSSALYEDR 
gi|31189 unnamed protein product 23,182 HLACLPR 
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supernatant collected from infected cells mainly contains parasite derived TLR2 
molecules as well as small amounts of TNF-! that triggers a TLR2 independent 
pathway. 
 
Supernatants collected from SAG1 deficient parasite infected cells have reduced 
TLR2 stimulatory activity 
To test whether SAG1 or TgSUB1 activates TLR2, we next tested the supernatant 
activity collected from SAG1 and TgSUB1 deficient parasites. SAG1 has been 
previously identified as the immunodominant surface antigen of T. gondii that is 
related to virulence and important for the initial stage of host invasion (32-34). The 
TgSUB1 is a GPI-anchored serine protease that is important for the proteolytic 
processing of microneme proteins (MIC) and is released from the surface of the 
parasite during invasion.  The TgSUB1 protein can also be secreted into the media 
with other micronemal proteins after host cell invasion. Here, we analyzed the TLR2 
stimulatory activity of infected supernatant from either SAG1-deficient parasites or 
TgSUB1-deficient parasites.  Both knockout strains do not have defects in growth 
when cultured in vitro (25).  Results show that supernatants from SAG1-deficient 
parasites have reduced TLR2 activity when compared to the parent RHD and the 
SAG1 complemented M34 strain (Fig 4.7 A).  However, infected supernatants from 
TgSUB1 deficient parasites complemented with either full length or control vector do 
not demonstrate reduced TLR2 stimulatory activity (Fig 4.7 B).  Therefore, these data 
suggests that the GPI-anchored protein SAG1 is important in activating TLR2. 
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Figure 4.7.  T. gondii tachyzoites deficient in the SAG1 gene have reduced 
TLR2 stimulating activity.  (A) HEK 293 cells transfected with TLR2 and 
an NF-!B luciferase reporter plasmids were stimulated with the TLR2 ligand 
Pam3Cys, or supernatants from RH" (wild type parent strain), SAG1 KO 
(RH" lacking SAG1 gene), or M34 (SAG1 KO complemented with SAG1) 
infected cells. HEK 293 cells lysates were assayed for luciferase activity. (B) 
Similar to (A) except for supernatants from cells infected with TgSUB1 KO 
complemented with control vector, or TgSUB1 KO complemented with full 
length TgSUB1 were used to stimulate the HEK 293 transfected cells. HEK 
293 cells lysates were assayed for luciferase activity (triplicate assays; error 
bar, SD).  *P<0.05, **P<0.01, media vs. treatment.   
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Supernatants from T. gondii infected cells enhance microparticle transport and 
induce DC movement in the follicle- associated epithelium of Peyer’s patches in 
vivo 
Mucosal immune responses to antigens are initiated at sites containing organized 
lymphoid tissues such as Peyer’s patches.  To test whether supernatants collected from 
T. gondii infected cells enhance M cell function, ligated intestinal loops were injected 
with fluorescent latex microbeads mixed with infected or control supernatants.  After 
60 minutes, the Peyer’s patch tissue samples were harvested and embedded in 
embedding medium. The sections from frozen tissue were stained with anti-laminin to 
visualize the boundary between the epithelium and the connective tissue.   Results 
showed that more microbeads were detected in the subepithelial dome of Peyer’s 
patch incubated with supernatants from infected cells (Fig 4.8).  The follicle 
associated epithelium also attracts DCs to the subepithelial dome region to enhance 
capture of antigens.  DC movement in the subepithelial dome is observed as early as 
90 minutes post stimulation with TLR agonists (23).  Therefore, to test whether 
supernatants from T. gondii infected cells induced the movement of DCs in the 
subepithelial dome, supernatant from infected and non-infected cells were injected 
into the lumen of the intestinal ligated loop and Peyer’s patch samples were collected 
after 90 minutes.   The frozen embedded tissue sections were stained for anti-CD11c+ 
and anti-laminin.   There was a significant increase in the number of CD11c+ DCs in 
association with or migrated into the follicle associated epithelial layer when ileal 
loops were exposed to supernatants from infected cells compared to the non-infected 
cells (Fig 4.9 A, right top and right bottom panel).  Together, these results demonstrate 
that supernatants from T. gondii infected cells enhance transport and induce rapid 
migration of DCs to the follicle associated epithelial in the Peyer’s patch. 
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Migration of DCs to the follicle associated epithelium in response to supernatants 
from T. gondii infected cells is MyD88 dependent 
We next asked whether the movement of subepithelial DCs induced by supernatants 
from infected cells was dependent on TLRs.  Intestinal ligated loops of MyD88+/+ or 
MyD88-/- mice were injected with supernatants collected from infected or non-infected 
cells, and tissues were harvested after 90 minutes.   The infected supernatant induced 
migration of DCs to the follicle associated epithelium in MyD88+/+ mice, but not in 
MyD88-/- mice (Fig 4.9 A).  Quantitative analysis demonstrated that MyD88-/- had 
similar counts as wild type mice treated with control supernatant (Fig 4.9 B).   These 
results suggest that T. gondii infected supernatants were able to induce a TLR-
dependent DC migration in the Peyer’s patch. 
 
DC migration in response to supernatants from T. gondii infected cells is absent 
in TLR2-deficient mice 
We next examined whether supernatants from T. gondii infected cells induced DC 
migration to the follicle associated epithelium in a TLR2 dependent manner.   WT and 
TLR2 deficient mouse surgical ligated loops were injected with supernatant from 
infected or non-infected cells for 90 minutes.  Although supernatants from T. gondii 
infected cells induce DC migration in wild type mice, TLR2 deficient failed to shown 
any DC migration (Fig 4.10 A, B)).   Importantly, DC migration in response to 
infected supernatant was not dependent on the interaction of profilin with TLR11, 
since DC migration was not impaired in TLR11 deficient mice and TLR2!11 double 
deficient mice recapitulated the phenotype observed in TLR2 deficient mice (Fig 4.10 
C, D).  Taken together, these results demonstrate that supernatants from T. gondii 
infected cells play a role in modulating follicle associated epithelium function and DC 
migration in a TLR2dependent manner.  
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Figure 4.8.  Supernatants from T. gondii infected cells enhance uptake of 
fluorescent latex beads.  Ligated intestinal loops were injected with fluorescent latex 
beads mixed with equal volumes of supernatants collected either from infected cells 
(supe-Tg) or non-infected (supe-control) cells.  Supernatants from T. gondi infected 
cells induce an increased uptake of fluorescent latex beads across the FAE at 60 
minutes (arrows), indicative of increased M cell activity. The white line defines the 
basal limit of the epithelium as determined by laminin staining, and arrows indicate 
some of the beads on the SED side of the FAE. 
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Figure 4.9. Supernatants from T. gondii infected cells induce the migration of 
dendritic cells (DCs) into the FAE in a MyD88-dependent manner.  (A) Peyer’s 
patch from wild type or MyD88 deficient mice were collected after 90 minutes of 
intraluminel injection of control (supe-control) or supernatant from T. gondii infected 
cells (supe-Tg).  Frozen tissue sections stained with anti- CD11c+ (red) and DAPI 
(blue) showed increased numbers of DCs in the FAE after exposure to supernatants.  
The dotted line defines the basal limit of the FAE as determined by laminin staining. 
Representative images show migrated CD11c DCs (arrows) to the FAE was induced 
upon exposure to supernatant from infected cells (supe-Tg) in MyD88+/+ mice, but not 
in MyD88 deficient mice. (B) Quantitative analysis of DCs that have migrated to the 
FAE in control (supe-Tg) or supernatants from infected cells (supe-Tg).  Data are from 
one experiment with one mouse for each treatment. 
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Figure 4.10. Supernatants from T. gondii infected cells induce migration of 
dendritic cells into the FAE is involves is TLR2 dependent.  (A) Peyer’s patch from 
wild type or TLR2 deficient mice were collected after 90 minutes of intraluminel 
injection of control (supe-control) or supernatant from T.gondii infected cells (supe-
Tg). Frozen tissue sections stained with anti-CD11c+ (red) and DAPI (blue) showed 
increased DCs in the FAE after exposure to supernatants.  The dotted line defines the 
basal limit of the FAE as determined by laminin staining.  Representative images 
show that the migration of CD11c+ DCs (arrows) was induced upon exposure to 
supernatants from infected cells (supe-Tg), but not in TLR2-/- mice.  (B) Quantitative 
analysis of DC migration into the FAE in WT or TLR2-/- mice (n=4).  Significance 
between DC migration between WT and TLR2-/- mice with different treatments are 
indicated (*, p < 0.05). (C) Similar experiments as described in (A) were performed in 
TLR2!11-/- and TLR11-/- mice.  (D) Quantitative analysis of DC migration to the 
FAE in TLR11-/- and TLR2!11-/- mice (n=2).  
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Discussion 
TLR2 was previously shown to play a role in host protection at low dosage of T. 
gondii infection (35).   In the chapter 3, we showed that oral infection with T. gondii in 
TLR2 deficient mice also resulted in less inflammation in the ileum, and less DC 
migration in the Peyer’s patches after infection. This suggests that early signaling in 
the mucosa may influence the outcome of the disease. TLR2 dependent cytokine 
production during T. gondii infection also differs among cell types.  For example, we 
previously reported that IL-8 secretion depends on TLR2 in intestinal epithelial cells 
(28). Studies with innate immune cells demonstrated that production of CCL2 by 
neutrophils and macrophages, and production of IL-12 in macrophages also depended 
on TLR2 (36).   In this study, we further demonstrate that the GPI anchored SAG1 of 
T. gondii tachyzoites plays a role in initiating inflammatory responses in intestinal 
epithelial cells, and DC movement to the follicle-associated epithelium of the Peyer’s 
patches, effects dependent on TLR2.    
 
Interactions between epithelial cells and DCs at mucosal surfaces are thought to 
provide a crucial link between innate and adaptive mucosal immunity (37-39).  In 
chapter 3, we showed that intralumenal injection with live T. gondii tachyzoites had a 
rapid, TLR2-dependent effect on the movement of DCs to the follicle associated 
epithelium within 90 minutes.  Here, we demonstrate that the stimulatory component 
from T. gondii is secreted into the supernatant of infected cells, and these T. gondi-
derived mediators promote antigen uptake and induce DC migration to the mucosal 
surface in a TLR2-dependent manner.  This response is consistent with previous 
studies done by Chabot and colleagues using TLR2 ligands as stimulus (23). 
Therefore, we speculate the TLR2-dependent DC migration would result in enhanced 
antigen capture followed by migration to the interfollicular region (IFR).   The 
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maturation of DCs is likely triggered by TLR2 dependent interaction with T. gondii 
derived antigens, such as SAG1, which stimulates high levels of IL-12 resulting in 
IFN-g secretion by T cells.   In support of this hypothesis, studies by Liesenfeld and 
colleagues have shown that high levels of locally produced IFN-g were observed in 
the Peyer’s patches of mice infected with T. gondii (40).   However, in a study using 
bone marrow derived DCs, heat killed or soluble tachyzoite antigen induced DC 
maturation, but live parasite infection did not (41).  Peyer’s patches contain different 
subsets of DCs in the subepithelial dome region. CD11b+ CD8a! DCs respond to 
CCL20 and CCL9, which are secreted by the follicle associated epithelium, while the 
CD11b! CD8a! DC subset expresses CX3CR1 and are in close contact with M cells. 
The CD11b-CD8a- DCs sample antigens by penetrating tight junctions between 
epithelial cells (42).  Thus, it would be interesting to analyze which DC subset in the 
Peyer’s patches is responding to T. gondii derived antigens and the subsequent T cell 
activation.   In addition, while both live parasite and supernatants containing T. gondii-
derived mediators trigger DC migration, the outcome of T cell activation could be 
different. T. gondii may subvert DCs dissemination (41, 43).   
 
T. gondii possesses multiple molecules that activate the MyD88-signaling pathway.  
Therefore, immune activation during T. gondii infection may involve multiple TLR 
ligands.  Two T. gondii molecules that activate TLRs have been identified to date.  T. 
gondii GPI anchors as well as core glycans and lipid moieties trigger NF-"B activation 
through TLR2 and TLR4 (18, 29).  Another TLR ligand derived from T. gondii is 
profilin, which induces DC production of IL-12 through TLR11 (19, 44).   Although 
we observed reduced TLR2 activity in the SAG1-deficient parasites, DC migration 
may be mediated by many GPI-anchored proteins rather than just one specific antigen.   
Since SAG1 is very abundant on the surface of tachyzoites, depleting SAG1 in the 
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parasites results in reduced TLR2 stimulatory activity.  In contrast, TgSUB1 is less 
abundant and deficient parasites did not demonstrate less stimulatory activity. 
Importantly, the migration of DCs in response to the T. gondii secreted factor is a 
TLR2 dependent event because we observed a defect of DC movement in TLR2!11 
double deficient mice, but not in the TLR11 deficient mice.    We have not analyzed 
the cytokine production from the Peyer’s patch DCs; however, while TLR2 dependent 
DC migration to the  follicle associated epithelium might enhance antigen uptake, it is 
possible that the production of IL-12 in DCs still relies on TLR11 dependent 
signaling.  
 
The initial site of infection for T. gondii is the mucosal surface; therefore, a strong 
inducer that stimulates mucosal immunity is important for developing effective 
vaccines against toxoplasmosis.  SAG1 is a strong inducer of immunity and is 
associated with virulence, as demonstrated by higher transcription levels in the 
virulent T. gondii strains (33). Kasper and colleagues demonstrated that SAG1 induced 
the expression of several chemokines that are important for inducing acute ileitis in 
susceptible C57BL/6 mice.  This suggests that SAG1 induces strong IFN-g production 
(20).  In vitro, SAG1, but not other T. gondii secretory proteins, directly induces the 
secretion of MCP-1/CCL2 (45).  Due to these immunostimulatory features, is often a 
candidate for designing DNA based vaccines to prevent toxoplasmosis (22, 46-49).   
However, most of the immunizations in these studies are inoculated intramuscularly or 
intranasaly to generate CD8+ T cell response, but not through the intestinal mucosa.   
Further studies are needed to define the role of SAG1 in inducing effective Th1 
response in the intestinal mucosa.  Our data suggest that SAG1 may act very early 
during infection and would therefore act as both an innate immune stimulator and 
antigen to which adaptive immunity is directed. This information may provide insight 
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for generating protective response against toxoplasmosis and benefit both medical and 
veterinary fields. 
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CHAPTER V 
DISCUSSION AND FUTURE DIRECTIONS 
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1.   Summary of findings 
In Chapter 2, the response of intestinal epithelial cells and signaling pathways during 
T. gondii infection was examined.   By using an in vitro system, the immediate 
response upon intestinal epithelial and parasite contact was measured.  Results from 
this chapter revealed that T. gondii infected epithelial cells elicited MAPK 
phosphorylation, NF-kB activation, and secretion of IL-8 as well as several other 
inflammatory cytokines and chemokines.  Specifically, activation of MAPK and 
production of IL-8 was dependent on the MyD88 signaling pathway.  However, while 
knocking down TLR2 in epithelial cells did not complete abrogate signaling, TLR2 
(both mouse and human) was sufficient for parasite induced signaling in HEK 293 
transfected cells.  Furthermore, the epithelial cells responded to T. gondii regardless of 
their genotype and virulence.   
 
In Chapter 3, modulation of the local intestinal environment and the morphological 
changes of different intestinal epithelial cell subtypes in response to peroral T. gondii 
infection were characterized.  Using an intestinal ligated loop model, live T. gondii 
tachyzoites induced a TLR2-dependent migration of CD11c+ cells, which are mostly 
dendritic cells, into the follicle-associated epithelium.    Direct infection of T. gondii in 
polarized intestinal epithelial cells enhanced barrier function and upregulated a 
subgroup of defensin mRNA transcripts.   Oral infection of C57BL/6 mice with T. 
gondii ME49 cysts induced intestinal pathology and morphological changes such as 
reduced numbers of goblet cells and Paneth cells as well as secretion of Paneth cell 
granules to the crypt lumen.  Interestingly, mice with similar genetic background but 
lacking TLR2 were more resistant to intestinal pathology and associated 
morphological changes observed following T. gondii infection in wild type mice.  
 
  164 
In Chapter 4, the TLR2 stimulatory molecules derived from T. gondii were 
investigated.    I found that supernatants from T. gondii cells activated signaling 
pathways in intestinal epithelial cells, a response similar to live parasite infection.  
Furthermore, supernatants collected from T. gondii infected cells activated NF-!B 
through TLR2.  Previous studies have shown that glycosyphosphatidylinositol (GPI) 
anchors derived from T. gondii are ligands for TLR2 and TLR4 (1).  The analyses of 
the supernatant revealed two GPI-anchored proteins from T. gondii: surface antigen 1 
(SAG1) and subtilisin (TgSUB1).  Supernatants collected from cells infected with 
SAG1-deficient parasites had reduced stimulatory TLR2 activity.   The potential 
biological significance of the activity in supernatants from T. gondii infected cells was 
also addressed.  Supernatants from T. gondii infected cells enhanced the uptake of 
antigens from the luminal of the small intestine and induced TLR2-dependent 
migration of dendritic cells to the follicle-associated epithelium of Peyer’s patches.   
 
2.  The role of intestinal epithelial cells in initiating inate immunity during T. 
gondii infection 
It is often questioned whether T. gondii infects intestinal epithelial cells or crosses 
epithelial barriers to gain access to deeper tissues (2, 3).    To cause systemic infection, 
the parasite must cross the intestinal epithelium, basement membrane, and lamina 
propria.  However, early studies on the kinetics of invasion and dissemination of T. 
gondii showed that parasites can be detected in the Peyer’s patch, lamina propria, and 
epithelial cells of the distal ileum after 1 hour oral ingestion of T. gondii cysts (4).  
Dissemination of the parasite to the periphery, lung, and liver was observed 24-48 
hours later (4).   This suggests that during the first 24 hours, the intestinal epithelial 
cells may be a target for parasite invasion and replication.  Therefore, signals initiated 
by intestinal epithelial cells are critical for the cross talk with the innate immune cells 
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underlying the lamina propria.   In this thesis, I initially used an in vitro model to 
study the intestinal epithelial response upon T. gondii infection.   Consistent with 
previous studies, I have also observed the induction of cytokines and chemokines 
important for neutrophil, dendritic cell, and macrophage chemotaxis.    
 
One of my interesting findings is the importance of TLR2 signaling during T. gondii 
infection.   TLR2 expressed in different epithelial cell types might play different roles 
during different stages of infection.  While signaling of MAPK and IL-8 is only 
partially dependent on TLR2 in enterocytes (results from chapter 2), the gate keeping 
function in the FAE and DC migration is dependent on TLR2 (results from chapter 3).  
The migration pattern of Peyer’s patch DCs is similar to previous reported using TLR 
ligands as stimulus (5, 6).  However, the reason for parasite induced DC migration 
towards the mucosal surface still remains unclear.  There are at least 2 possible 
explanations for parasite induced DC migration.  First, the effect is due to a host 
defense mechanism.  In the case of Salmonella typhimurium, a subset of DCs 
expressing CCR6+ reside in the Peyer’s patch and were recruited to the subepithelial 
dome regions upon bacterial invasion. These cells were responsible for the rapid local 
activation of pathogen-specific T cells (7).  Whether this is the case during T. gondii 
infection remains to be explored.  Second, induction of DC migration to the mucosal 
surface might be induced by T. gondii to cause migration of leukocytes. These 
leukocytes would then be infected and used as Trojan horses to disseminate the 
organism in the host while avoiding immune attack, an evasion mechanism that has 
been proposed by previous studies (8, 9). 
 
While the results in this thesis showed the importance of TLR2 in the “early” 
signaling of T. gondii at the Peyer’s patch and epithelial cells, there is still a missing 
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link in how T. gondii induced TLR2-dependent early signaling events can effect the 
disease outcome. T. gondii-induced ileitis is only observed in mice on the C57BL/6 
genetic background, whereas other mouse strains are resistant to this pathology.   
C57BL/6 mice lacking TLR2 display different levels of pathology during oral 
challenge with T. gondii when raised in different facilities (results in chapter 3 
compared to results published by Yarovinsky and colleagues (10). Emerging studies 
have now demonstrated that bacterial recognition through TLRs can shape the 
intestinal function through recognition of commensals (11-16).  Differences in the 
composition of the gut commensals can modulate the mucosal immune balance as well 
as the immune responses against intestinal pathogens.   This is supported by the recent 
identification of a specific commensal member in the small intestine, a non-culturable 
Clostridia-related species named segmented filamentous bacteria (SFB).  The 
colonization of SFB can coordinate the maturation of intestinal T cell adaptive 
functions in the gut mucosa (17-19).   SFB is also know to adhere to the Peyer’s patch 
in addition to the ileal mucosa and may play a role in initiation of T cell responses.  It 
has been shown that colonizing SFB can induce IL-17, IL-10, CD40L, and IFN-! 
mRNA transcripts in the Peyer’s patch (19).  Whether the colonizing of SFB in 
different TLR deficient mice results in mucosal susceptibility to pathogens is not yet 
know.  However, it is possible that the presence of SFB, which can skew the mucosal 
effector T cell balance, plays a role in shaping the mucosal immune response during T. 
gondii infection. Future studies on analyzing the gut microbiome in wild type, TLR 
knockout mice, as well as mice raised in different environments can help us 
understand how commensals participate in regulating mucosal functions, which may 
be importance of explaining the difference in disease outcome of T. gondii infections. 
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3.  T. gondii derived TLR ligands and their role in initiating mucosal immunity 
Two TLR ligands derived from T. gondii have been identified to date.  T. gondii GPI-
anchored proteins activate TLR2/4, and T. gondii derived profilin-like protein is 
recognized by TLR11 (1, 20).  In chapter 4, my results suggest that the dominant GPI-
anchored surface protein (SAG1) of T. gondii was important for NF-!B activation via 
through TLR2. These observations raised the possibility that T. gondii possesses 
different molecules that are recognized at different stages by the host innate immune 
system.  The activation of TLR2 in the mucosal epithelum during T. gondii infection 
may be important for mucosal immune responses, whereas T. gondii profilin is 
important for IL-12 production through TLR11 stimulation in dendritic cells (20).   
 
The surface protein of tachyzoites SAG1 is highly immunogenic.  Studies published 
by Kasper and colleagues showed that SAG1 knockout parasites have a reduced 
ability to induce ileitis following intralumenal infection, and that the infection is 
associated with increased parasite burden and decreased innate and adaptive immune 
responses.  Infection with SAG1 knockout parasites also affects the capacity of 
intestinal epithelial cells to secrete chemokines (21).  This study supports my findings 
on the reduced TLR2 stimulatory activity, and a defect in DC movement in the Peyer’s 
patch in mice lacking TLR2 when treated with supernatants from SAG1-deficient 
parasites.  This suggests that while TLR2 recognizes T. gondii GPI-anchored proteins, 
due to the dominance of SAG1 present on the surface of the parasite, T. gondii SAG1 
could be the main factor contributing TLR2 signaling. 
 
4.  Future directions 
My finding of intestinal epithelial response during T. gondii infection raises several 
interesting questions.  It is not clear how TLR2-dependent migration of DCs to the 
  168 
follicle associated epithelium is triggered.  There are at least two possibilities that can 
be addressed:  (1) The TLR2 expressed in the follicle associated epithelium 
enterocytes are activated upon encountering the parasite, which causes rapid short-
term release of chemoattractants, such as CCL20, to recruit DCs in the subepithelial 
dome, and (2) the effect is solely dependent on the DCs with in the Peyer’s patch.  The 
first possibility requires signaling to upregulate gene transcription, followed by 
translation, folding, processing, secretion of chemokines, diffusion of those 
chemokines and activation of the CD11c+ cells, all within the 90 minutes of the 
experiment. While this seems unlikely, it is possible that the epithelial cells have 
prestored chemokines or other non-transcription dependent signaling molecules that 
could act as chemoattractants.  Therefore, the possibility that factors secreted by T. 
gondii penetrate the epithelial junctions and act directly on the dendritic cells. It would 
be interesting to test the effect of DC migration using TLR2flox/flox Villin-cre or 
TLR2flox/flox CD11c-cre mice during T. gondii infection to determine whether the effect 
is directly on the DCs.  
 
My results from in vitro and in vivo infection of T. gondii revealed the induction of 
several cytokine and chemokine mRNA transcripts. Defect or overexpression of 
certain cytokines can affect innate immune cell homing and maturation and alter the 
disease outcome.   Most studies on T. gondii-induced pathology have focused on TLR 
deficient mice. However, the associated intestinal immunopatholology can also 
involve other cytokines/receptors as well.  This is shown by the resistant phenotype of 
T. gondii-induced pathology in CCR2-deficient mice (22). The functional role of these 
inflammatory cytokines upregulated in epithelial cells during during T. gondii 
infection can be addressed in future studies. For example, the chemokine MIP3-
a/CCL20 expressed at high levels in the follicle associated epithelium is the 
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predominant chemokine that attract and maintain the abundance of CCR6+ DCs to the 
subepithelial dome region of the Peyer’s patch (23, 24).  This gene was also 
upregulated during early infection of T. gondii in intestinal epithelial cells (results in 
chapter 2).  Therefore, it is possible that depletion of this chemokine would result in 
decreased clusters of DCs in the subepithelial dome region and initiation of T cell 
response during infection, thus increasing susceptibility to T. gondii infection. 
 
The Peyer’s patch has been considered the major inductive site for IgA, and the DCs 
in the Peyer’s patch play an important role in this production. Mice orally infected 
with T. gondii develop intestinal IgA antibodies to SAG1 (25).  I have shown that both 
live T. gondii and T. gondi-derived molecules induce DC migration within Peyer’s 
patches.  This raises the possibility that the migrated DCs participate in the uptake of 
antigens.  However, immunohistochemical and functional analysis of the Peyer’s 
patch DCs has revealed three distinct populations. DCs in the subepithelial dome 
(SED) dominantly express CD11b, DCs in the interfollicular region (IFR) express 
CD8a, and a double negative DC subset are localized in subepithelial dome region, 
IFR and follicle associated epithelium (26-28).  These three DC subsets possess 
distinct abilities to induce CD4+ Th1 or Th2 differentiation.   Therefore, future work 
needs to be done on further analysis of the DCs subsets that have migrated to the 
follicle associated epithelium.  This information will help us understand the 
mechanism of immune induction in the Peyer’s patch during T. gondii infection. 
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